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 The overall objective of this study was to apply a variety of molecular 
techniques to determine the etiology and epidemiology of Candida spp. infections 
in Central Vietnam. 
MALDI-TOF Mass Spectrometry correctly identified 94.9% of 196 Candida 
spp. isolated strains. The remaining unidentified species (5.1%) were detected by 
ITS gene amplification and sequencing. A variety of Candida species were isolated, 
with the most common species being C. albicans (47.96%), followed by                 
C. tropicalis (16.33%), C. parapsilosis (10.71%), C. glabrata (8.67%),                   
C. orthopsilopsis (5.61%), C . krusei (3.57%) and others species.  
Antibiotic susceptibility showed higher rates of resistance to fluconazole in 
C. tropicalis (56.67%). Two specific missense mutations in the ERG11 protein 
(Y132F and S154F) were detected from 26.67% of fluconazole resistant                  
C. tropicalis isolates. 
 96.81% of C. albicans isolates carried all three virulence genes (als1, hwp1, 
sap4) regardless of the sample source, that was concordant with a higher frequency 
of C. albicans in mucosal candidiasis compared to a higher frequency of          
C. non albicans in candida colonizations. 
A total of 12 C. albicans diploid sequence types (DSTs) were identified from 
ten different wards by Multi Locus Sequence Typing (MLST). Of the 12 identified 
DSTs, six were new DSTs assigned by this study. Based on C. albicans cluster 
analysis,  66.67% of the isolates clustered with previously known clades in global or 
Asian data, and 33.33% isolates were singleton. MLST results suggested a potential 
nosocomial transmision of C. albicans since the same DTS clones were found in 
different wards.  
Amplification of specific H. pylori gene (ureA) was applied to find a 
presence of this bacteria in Candida cells. Positivity was detected in 15.27% of 
Candida spp. (C. albicans, C. tropicalis, C. orthopsilosis) isolated from oral 
mucosa, sputum, vagina, and gastric fluid. 
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1. INTRODUCTION 
1.1. Candida species 
1.1.1. History  
The original name of Candida comes from the Latin term “candidus”, 
meaning “glowing white,” which relates to the creamy and glistening white 
characteristic of yeasts colonies on culture media. This fungi is responsible for oral 
thrush, an infection that has been recognized for over 2000 years [1]. Candida 
infection, or „candidiasis‟, is also known as „candidosis‟ or „moniliasis‟.  
Candida albicans (C. albicans) was identified in the nineteenth century from 
three independent sources. First, in 1841, Fredrick Berg, a Swedish medical 
pratitioner, discovered that thrush was caused by fungus with filaments that 
dispersed into epithelial cells. Then in 1842, David Gruby, a medical practitioner in 
Paris, fully described the cells of thrush fungus and compared to that causing tinea. 
Thrush fungus was later named in 1853 as Oidium albicans by Charles Phillipe 
Robin. In 1868, Charles Quinquaud renamed the fungus to Syringospora robinii. 
The name was changed again to Monilia albicans in 1890 by Wilhelm Zopf. 
Around this time, detailed drawings of the fungus revealed the following 
characteristics: budding cell, pseudohyphae, hyphae, and dimorphism. In 1923, 
Christine Berkhout, a Dutch mycologist, changed the name of the fungus to 
Candida albicans [2, 3].  
In addition to infecting the oral cavatities, Candida infects other parts of the 
body, including oesophageal, vaginal, cerebral, and intestinal lesions, etc. [2]. 
1.1.2. Taxonomy and mycology 
The heterogeneous genus Candida belongs to the Kingdom: Fungi, Phylum:  
Ascomycota, Subphylum: Ascomycotina, Class: Ascomycetes, Order: 
Saccharomycetales, Family: Saccharomycetaceae, Genus: Candida. The genus 
contains approximately 200 species [4] 
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The taxonomy of the genus Candida is increasing overtime because of the 
reclassification of certain species (e.g., Torulopsis glabrata has been correctly 
identified as C. glabrata), and the discovery of new species such as C. dubliniensis, 
C. orthopsilosis, and C. metapsilosis. C. orthopsilosis, and C. metapsilosis were 
previously classified as part of the C. parapsilosis complex [5]. Futhemore, some 
species have been classified under C. albicans, including C. claussenii and C. 
langeronii. Recently, some new Candida species were distinguished from C. 
albicans, such as C. albicans var. africana, a new sucrose-negative variant of C. 
albicans that is closely related to C. stellatoidea type II [6].  
More than 200 species of Candida have been described, most of which exist 
as saprophytes orgnisms. Half of  the described species can not grow at 37
0
C, 
making them unsuccesful as human pathogens. Approximately 30 species can infect 
humans. C. albicans is the most prevalent species, followed by other pathogenic 
species which include C. glabrata, C. tropicalis, C. parapsilosis, C. krusei, C. 
guilliermondii, C. lusitaniae, C. kefyr, C. inconspicua, C. famata, C. rugosa, C. 
dubliniensis, C. norvegensis, C. lipolytica, C. sake, C. pelliculosa, C. apicola, C. 
zeylanoides, C. valida, C. intermedia, C. pulcherrima, C. haemulonii, C. 
stellatoidea, C. utilis, C. humicola, C. lambica, C. ciferrii, C. colliculosa, C. holmii, 
C. marina,  and C. sphaerica ect [7].  
C. albicans, C. glabrata, C. parapsilosis, C. tropicalis and C. krusei account 
for 90-92% of all cases of candidiasis [8, 9]. The Candida pathogenic species list is 
expanding rapidly [7]. 
1.1.3. Morphogenesis 
Genus Candida constitute a heterogeneous group of eukaryotic, dimorphic, 
or polymorphic organisms [10, 11]. All Candida species grow as yeast cells or 




C, with growth 
augmented by increased sugar or fat content in the media. Yeast cells are 
approximately 2-10µm in the largest dimension, round to oval, and reproduce by 
budding. C. albicans is among the larger yeast at 4-6 x 6-10µm, whereas C. 
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glabrata and C. parapsilosis are among the smallest at 1-4 x 2-9µm and 2-4 x 2-
9µm, respectively [5]. They multiply principally by the production of blastoconidia 
(buds). As normally, blastoconidia of Candida spp. in microbiota gut of being 
human or animal exits in round, oval shape, but they could have different 
morphogenesis depending on the species [10, 12]. When blastoconidia are produced 
from one another in a linear fashion without separating, a structure termed a 
pseudohypha is formed. Under certain circumstances, such as growth under reduced 
oxygen tension, some yeasts may produce true hyphae. Most members of the genus 
produce filamentous forms (pseudohyphae or true hyphae). C. parapsilosis forms 
pseudohyphae but not true hyphae. C. dubliniensis, C.tropicalis and C. albicans 
form true hyphae [5, 12]. The presence of budding yeasts, pseudohyphae or hyphae 
in infected tissue are usually indicative of candidiasis [13, 14]. C. glabrata is the 
only pathogenic species that does not produce filamentous forms, existing 
exclusively as blastoconidia [12]. 
 
Figure 1.1. Candida spp. morphology 
(www.tcd.ie/Biology_Teaching_Centre/assets/pdf/by2205/by2205- 
webgalleries2011/by2205-gallery1/candida.pdf) 
1.1.4. Cell biology and enzymology 
Candida spp. growth characteristics,  metabolic  features  and enzymology 
characteristics are the same to those of eukaryotes and especially similar to 
Saccharomyces cerevisiae [10]. 
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Polysaccharides are an essential compound in the cell walls of Candida 
species [10, 15]. Candida cell walls are composed of mannans, glucans and a small 
amount of chitin (Figure1.2) [10, 16, 17]. These components are closely bound to 
polypeptides and proteins found on the cell membrane [16]. Three types of adhesion  
molecules were observed [18]: (1) glycoproteins which are expressed specifically  
on  the  surface  of  hyphae  form, (2) the protein moiety of glycoproteins which 
binds to host glycosides containing fucose or N-acetyl glucosamine, and (3) the 
polysaccharide portion of a mannoprotein. Furthermore, the  structure  of  mannan  
polysaccharides found on the walls of Candida plays a potent role in its 
pathogenicity [10, 19]. C. albicans mannan masking of glucan and yeast hypha 
morphogenesis are required for disruption of host processes that function to 
inactivate pathogens, leading to survival and escape of this fungal pathogen from 
within host phagocytes [20]. 
Phospholipids and sterols are dominant in lipids structure of Candida spp. 
Ergosterol is the major membrane sterol. These lipids provide the site of action for 
the synthesis of enzymes involved in cell wall morphogenesis and antifungal action. 
Lipid alterations can occur during a yeast to mycelium transition [21]. Additionally, 
Candida spp. are constantly changing the structure of enzymically active proteins 
such as enolase and N-acetyl glucosaminidase, ubiquitin like epitopes  and  a  
protein  related  to  the heat shock protein family (hsp70 and hsp 90) [10, 11]. 
 
Figure 1.2. Structure of the C. albicans cell wall [19]. 
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Candida spp.  can  grow in wide a pH  range,  from below 2.0 to nearly 10 
[22], and under microaerophilic and even anaerobic conditions  as  well  as  the  
more  normal  aerobic atmospheres of incubation. Glucose, galactose and sucrose 
are  all substrates for growth of the fungus, and nitrogen requirements can be met by 
relatively low concentrations of ammonium ions.  
Many enzymes of C. albicans and C. non albicans have been characterized. 
Secreted aspartyl proteinases (SAP), one of the most studied enzymes, produce by 
C. albicans, C. parapsilosis, C. tropicalis, C. dubliniensis, C. guilliermondii, C. 
kefyr, C. lusitaniae, and C. krusei [23-25]. These enzymes produce non specific 
proteolysis of host proteins involved to defend against  infection. Their different 
profiles of pH dependent irreversible denaturation may  partially explain differences 
in virulence of Candida species [25]. The sap gene family in C. albicans includes at 
least 10 isoenzymes which are referred to as SAP1 through SAP10 [25]. Different 
SAPs are associated with a different location within the yeasts and different 
pathogenocity [25]. SAP1-3 expression is dominant in mucosal and cutaneous 
candidosis, whereas SAP 4-6 may be important for systemic disease [10, 25] and 
could induce apoptosis of epithelial cells by a novel Trojan horse mechanism [26].  
C. albicans, C. dubliniensis, C. glabrata, C. krusei, C. lusitaniae, C. 
parapsilosis, and C. tropicalis also produce phospholipases [10, 27]. These 
enzymes play an important role in controlling of yeast growth, remodeling of  
fungal cell membranes and spreading in host tissues through hydrolysis of  
phospholipids  [28]. Phospholipase B is important in C. albicans virulence, and it is 
secreted by the yeast during the infection process [28, 29]. 
1.1.5. Candida spp. from gut commensal to pathogen 
 Candida species are human commensals [30], commonly found on the 
mucosal surfaces of gastrointestinal and genitourinary tracts, skin, and under 
fingernails, and belong to human mycobiota (Figure 1.3) [5, 10, 31]. Moreover, C. 
albicans is also isolated from various sources, such as the atmosphere, fresh water, 
sea water and  soil [10]. 
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 The prevalence of Candida colonization varies depending on site and 
population sampled, and sampling method. It is estimated that between 25-40 % of 
people are colonized by C. albicans at any given point [11], this rate is 
approximately 6% (2-37%) among healthy person for oral Candida colonization 
and  approximately 47% (13-76%) in hospitalized  patients [10]. These figures 
could be higher in patient having high risks factors. For example, oral carriage rates 
may be higher in certain situations such as in HIV infected patients with low CD4 
counts, denture users with denture stomatitis, diabetic patients, patients receiving 
antineoplastic chemotherapy and  children [10]. It is believed that 100% of humans 
may carry one or more Candida species in the gut from the duodenum to the colon.  
The numbers of yeasts carried at any point in the gut can increase to levels that may 
become detectable in the mouth and feces in illness or other situations where the 
host‟s microbial suppression mechanisms become reduced. 
 
Figure 1.3. The human mycobiota [31] 
Candida spp. become pathogens in situations where the host‟s resistance to 
infection is lowered locally or systemically [11, 32]. As opportunistic pathogens, 
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they can damage local mucosal epithelium and sometimes, systemic infections in 
which they can spread to all major organs and colonize in these organs. There are 
several steps in tissue invasion by C. albicans: (1) adhesion to the epithelium; (2) 
epithelial penetration and invasion by hyphae; (3) vascular dissemination, which 
involves hyphal penetration of blood vessels and seeding of yeast cells into the 
bloodstream; and (4) endothelial colonization and penetration during disseminated 
diseases [19]. This process is shown in Figure 1.4. 
.  
Figure 1.4. The steps of C. albicans tissue invasion [19]. 
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The switch from commensalism to pathogenesis in Candida spp. depends on 
both fungal and host factors. Some essential fungal factors include adhesion, 
dimorphism, biofilm formation and hydrolytic enzyme [32].  
1.1.6. Candidiasis epidemiology 
Candidiasis refers to infection caused by any of  more than 200 species of the 
genus Candida. This fungi is capable of causing several different types of diseases, 
ranging from commonly encountered superficial infections (oral candidiasis, 
intertriginous candidiasis, ungual and periungual candidiasis, angular chelitis, 
vaginitis, chronic mucocutaneous candidiasis) to rare, candidaemia, systemic 
diseases [32-34]. Systemic infections are normally caused by endogenous Candida 
spp. escaping the gastrointestinal tract and circulating via the bloodstream to infect 
deep tissues such as the lungs, kidney, and liver [5]. Candidiasis is usually caused 
by C. albicans, and some time by other species (C. parapsilosis, C. tropicalis, C. 
krusei, C. glabrata, C. stellatoides etc.). 
Candida spp. are the fourth most common cause of nosocomial bloodstream 
infections (BSI) in the United States with a 35% to mortality rate. According to 
Centers for Disease Control and Prevention (CDC), approximately 46.000 
healthcare associated Candida infections occur among hospitalized patients in the 
United States each year with 30% of patients with candidemia with drug resistant 
Candida die during hospitalization. Additionally, drug resistant Candida infections 
results in millions of dollars in excess costs to U.S. healthcare expenditures each 
year [35].  
In the world, it estimated that there are 72.8 million Candida opportunistic 
infection cases per year [36]. The increasing rate of invasive fungal pathogens is 
related to the increasing number of critically ill patients and the use of a broad 
spectrum of antibiotics, surgical procedures, cytotoxic therapy with prolonged 
neutropenia, other immune suppressive therapies, indwelling invasive devices, and 
intensive care support. Candida spp. are the most prominent invasive fungal  
infection in  critically  ill  adult  patients as well as in neonatal patients treated in the 
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Intensive care units (ICU), and the second cause of invasive fungal infection in 
severely immunocompromised  patients such as those with cancer and recipients of  
hematopoietic stem cell and bone marrow or solid organ transplantation. It is 
estimated that 0.5-1% patients having high risk factors will contract Candida 
bloodstream infection, which contributed to 8-10% of all  nosocomial  bloodstream 
infections. Approximately 20-50% of these patients will die as a result of the 
infection, and an additional 10-40% will die from underlying disease (Figure 1.5) 
[37]. 
 
Figure 1.5.  Hospital - acquired Candida infections [37] 
Although C. albicans is the most common cause of invasive fungal 
infections, the increasing number of  infections from C. non albicans species is 
reported as a major source of infection [7, 38]. The ARTEMIS Global Antifungal 
Surveillance Program determined that C. albicans was the most common cause of 
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invasive fungal infections (63-70%), followed by C. glabrata (44%), C. tropicalis 
(6%), and C. parapsilosis (5%) [39]. However, the species distribution of C. non 
albicans varies by location and istitution of source reports. In most surveys 
conducted in US and Europe, C. glabrata is the second most common Candida 
species leading to invasive fungal infections [9] [40]. By comprison, in Asian - 
Pacific countries and Latin America, C. tropicalis and C. parapsilosis are the 
second and third most common Candida species, respectively [40]. Worldwide, 
there is a decrease in frequency of C. albicans and  an increase in C. parapsilosis 
and C. tropicalis, while the frequency of C. glabrata and C. krusei has remained 
unchanged. In addition, patient characteristics and time period using antifungal 
therapy also have an influence on the species distribution of this genus. C. albicans 
is more frequent in patients aged 18 years and younger, the frequency of C. 
parapsilosis decreases with age, and C. glabrata is more common in the elderly [9]. 
1.1.7. Diagnosis of candidiasis 
Candidiasis diagnosis 
For Candida spp. isolated from sterile sites, including blood and peritoneal 
fluids, intravenous line tips and tissue, should be identified to species level by 
sending to a specialized laboratory if necessary, exception of bronchoscopy fluid 
[41]. It is very important to classify between candida colonization and candidiasis 
for Candida spp. isolated from unsterile sites, such as urine, vaginal secretion, 
gastrointestinal fluid, stool, ect. In these cases, the observation of hyphae or 
pseudohyphae by direct microscopy can help to detect the infection. In addition, not 
all Candida spp. form filaments during infection (e.g. C. glabrata), and microscopy 
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According to The European Society of Clinical Microbiology and Infectious 
Diseases (ESCMID) [42], candidiasis diagnostic was recommended as follow: 
Table 1.1. Summary of recommendations by Candida disease, specimen and test 
evaluated [42] 

































































Use validated test only 
Candida spp. phenotypic identification 
Different methods have been developed and used since 1950s for Candida 
spp. identification [34]. The gold standard technique of phenotype identification is 
based on culturing strains followed by identification of different phenotypic 
characteristics. The detection techniques includes germ tube test, chromogenic test, 
enzymatic test, and fermentation tests [43, 44].  
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The most convenient and common methods for Candida species 
identification is carbohydrate assimilation and/or enzyme detection. This method 
proceed in strips or plates, which are commercially available. These commercial 
availbe test include the API 20C AUX (bioMerieux-Vitek, France), the API 
Candida (bioMerieux, France), the Auxacolor (Sanofi Diagnostics Pasteur, France), 
and the Uni Yeast Tek kit (Remel Laboratories, Lenexa, Kansas, USA). These tests 
use an increase in turbidity (API 20C AUX) or the production of color (API 
Candida, Auxacolor, Uni YeastTek) in each of a series of wells containing different 
substrates to produce a particular biochemical profile. The profile produced is read 
and translated into a numerical code that is deciphered using the manufacturer‟s 
reference manual. However, a disadvantage of these tests is that they are unable to 
differentiate between C. albicans and several species such as C. dubliniensi, C. 
tropicalis, C. lusitaniae [45].  
Additional methods for Candida spp identification was chromogenic media 
such as CHROMagar Candida (France), Oxoid Chromogenic Candida Agar 
(USA),  HiCrome Candida agar (HiMedia, Mumbai, India). These media help to 
differentiate Candida spp. by combine substrates linked to chemical dyes in a solid 
medium to made different color depend on species: C. tropicalis (dark blue 
colonies), C. albicans/C. dubliniensis (green colonies) and C. krusei (dry, irregular, 
pink-brown colonies). This medium is very useful for the identification of common 
Candida pathogenic species [46-48].  
Unfortunately, two major limitions of current test methods are test time and 
test sensitivity. It is known that current tests are time consuming and are not 
sensitive enough to give the accurate results. This results in the delay of  necessary 
antifungal therapy. Additionally, current test methods may not be sensitive enough 
to identify strains from different tissue specimens due to low number of cells 
present in different internal organs especially in case of invasive candidiasis. In 
summary, the limitations of Candida spp. identification based on phenotype 
includes  long testing time requirement and inability to differentiate between several 
species. 
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Another method to diagnose candidose is immunological test which is the 
detection of antigen or antibody. The detection of antibodies against 
different Candida antigens may help in the diagnosis, but may not be able to 
differentiate between species. Futhermore, the methods traditionally used for the 
detection of antibodies have been based on crude antigenic fungal extracts, which 
generally have low reproducibility and  have problems with cross reactivity [49]. 
Candida spp. genotypic identification 
The limitations described above for phenotypic identification techniques 
have led to the development of technologies to quickly and accurately identify 
Candida strains that will result in early diagnosis, treatment and management of 
candidemia and other infections caused by Candida species. Currently, three are 
three advanced methods that have been developed to identify Candida. These are 
polymerase chain reaction based Candida detection, MALDI - TOF MS and DNA 
Microarray for Candida detection [34, 43]. 
 Polymerase chain reaction (PCR). A large number of different protocols 
have been developed over the last five decades to identify different fungal strains 
present in clinical specimens by polymerase chain based Candida detection 
techniques. Various Candida DNA markers include 5.8S rRNA genes, 18S rRNA 
gene, small unit rRNA gene, noncoding internal transcribed spacer (ITS) of rRNA 
genes, and lanosterol demethylase gene have been used for detection of Candida 
species. This technique also help to identify species base on specific primers. In 
addition, real-time PCRs  is more sensitive and less time consuming techniques  for 
rapid and accurate identification of different Candida species [34].  
Matrix assisted laser desorption ionization time-of-flight mass 
spectrometry (MALDI-TOF MS). This technique is very useful in medical 
diagnostic for the rapid identification of clinically important bacteria and yeasts. In 
recent years, this technology has been applied to Candida biology in save timme 
manner and accurate identification. MALDI-TOF MS has been useful for 
identifying Candida species that are not easy to differentiate in the phenotypic 
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identification. Base on this technology, it could be discrinimate closed species such 
as C. parapsilosis, C. orthopsilosis, and C. metapsilosis as well as closely related 
species like C. dubliniensis /C. albicans , C.  glabrata/C. bracarensis [50] 
 DNA Microarray. This techniques has revolutionized the understanding of 
molecular functioning of different genes in all the organisms including humans. In 
the oligonucleotide microarray method, specific probes targeted to internal 
transcribed spacer 2 (ITS2) can be used for hybridization with fungal DNA 
amplified by PCR from different species. This method is sensitive enough to 
discriminate among different fungal pathogens at species level and can detect as 
low as 15 pg/ml  of DNA [51]. The sensitivity of the assay for C. albicans is 10 
cells/mL [52].  
In conclusion, molecular techniques have higher efficiency, specificity and 
sensitivity to the identification of Candida from culture and samples. 
1.2. Candida spp. virulent factors 
Invasion of  host  cells by Candida spp. progresses in several phases.  
Initially, blastospores adhere to epithelial cells, then hyphae are formed which 
penetrate cells actively or by endocytosis, progressively causing damage over time 
to the tissue. Several agents called virulence factors, are responsible for this  
process,  among  which  the potential  ones  are  the  ability  to  grow  at  37°C  and 
physiological pH, the size enabling invasion of the human  body;  the  others  are:  
formation of hyphae and pseudohyphae, the ability of phenotypic switching,  
adherence to epithelial and endothelial cells, biofilm formation, secretion of 
hydrolytic enzymes (proteases, phospholipases, lipases), and thigmotropisms [23, 
53, 54].  Each of  these  attributes  influences  the other, and all are essential for full 
pathogenicity of fungi from the genus. There is a growing number of studies 
reporting virulence factors of Candida spp., several virulence factors including 
adhesion molecules, hydrolytic enzymes, phenotypic switching, morphological 
dimorphism, and fitness attributes have been identified (Figure 1.6) [32]. 
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Figure 1.6. An overview of selected virulent factors distribute to C.albicans 
pathogenicity mechanism [32]. 
Adherence of Candida spp. to host tissues and cells is seen as an essential 
early step in the establishment of disease [23, 55]. The presence of specific 
compound in the fungal cell wall, most of which belong to the class of 
glycosylphosphatidylinositol cell wall proteins such as HWP, ALS, EPA, which 
promote adhesion to the proteins or carbohydrates in the host cell wall.  
One of the most important genes responsible for the adhesion process, whose 
expression is induced by physical contact between the fungal and epithelial cells, is 
hyphal wall protein 1 (HWP1). It is a fungal cell wall mannoprotein specific for 
germ tubes and hyphal forms [16]. HWP1 adhesin is controled by Kex2 
endoproteinase, which itself  also relates the activity of C. albicans proteinases, 
indicating its play for providing virulence and drug resistance of C. albicans. 
Although HWP1 detecting both in carriers of C. albicans and patients with 
candidosis of the oral cavity or vagina,  expression of this gene is higher among  
strains isolated from candidosis patients [55].  
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Agglutinin like sequence (ALS) are encoding a fungal cell surface 
glycoproteins, a type of adhesins that exhibit similarity to immunoglobulins, bind to 
peptide ligands of human cells and form aggregates with other microorganisms 
potentially pathogenic to human, which may lead to mixed infections. This family 
includes eight genes, although not all are present in each strain: als1-7 and als9 [53, 
55], from which als1-4 encode adhesins specific for germ tubes and hyphae [55, 
56], while als5-7 and als9 are associated with blastospores [55]. The transcription 
of all family genes in vitro and during infection has been detected in C. albicans, 
but some genes (als6 and als7) have been observed with only low levels of 
expression [16]. The genes most frequently reported to be involved in adherence for 
C. albicans are als1, als3 and als5, which are characterized by their ability to adhere 
to a wide variety of substrates [16, 54]. In C. tropicalis and C. dubliniensis had at 
least 3 als genes, which have been identified by southern analysis and western 
blotting with an anti ALS antibody [23]. 
Another virulence factor is extracellular hydrolytic enzymes, including the 
secreted aspartyl proteinase (SAP) and phospholipase (PLB) gene [16]. These 
enzymes acting as virulence factors which contribute to host tissue invasion by 
digesting proteins (hemoglobin, keratin, collagen…). Comparing to C. albicans, C. 
non albicans produced at a lesser extent hydrolytic enzymes.  
SAP are encoded by genes located on the same chromosomes as ALS, occur 
in similar numbers and and are regulated by similar mechanisms. C. albicans 
possesses at least 10 members of a sap gene family, all of which have been 
sequenced and extensively characterized. It was found that sap1, sap3, sap4, sap7, 
sap8 expression was correlated with oral disease. Furthermore, sap1, sap3, and sap8 
were preferentially expressed in vaginal rather than oral disease. In vitro studies 
show that sap1, sap2, and sap3 are expressed by yeast cells only, whereas sap4-6 
expression is confined to hyphae [23]. Sap1-4 genes were identified in C. tropicalis 
and sap1 is the predominant enzyme produced in vitro [23]. Sap genes also have a 
play in adhesion. The glycosylphosphatidylinositol-linked aspartyl proteases (Yps) 
is related to virulence of C. glabrata [53]. 
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 Four types of phospholipases have been revealed in C. albicans, including 
phospholipases A, B, C and D [23], but only the phospholipases B1 and 
phospholipases B2  products have been detected extracellularly [16, 23]. Although 
phospholipases B1 is thought to account for most of the secreted phospholipase B 
activity in C. albicans, phospholipases B2 contributes in a minor way, because a 
phospholipases B1 deficient strain still produces residual amounts of phospholipase 
B activity. 
 One contribution to Candida spp. virulence is hyphal formation, which 
makes a majority of the strains in this genus become dimorphism. Genes involved 
in these functions (Als3, sap4-6, hwp1, hyr1, and ece1) in C. albicans are 
differentially expressed [53]. The mitogen activated protein (MAP) kinase, cyclic 
AMP (cAMP), and pH sensing, Rim101 signal transduction pathways regulate 
cellular morphology and expression of hypha associated genes. The bud hypha 
transition may also contribute to virulence of other Candida species such as C. 
glabrata, even though C. glabrata strains do not exhibit germ tube formation in 
classical mycological assays [53]. 
C. albicans colonies can change among different phenotypes including 





) [57, 58]. Smooth and white colonies with round ovoid cells (white) 
can switch to flat and gray colonies with elongated or bean shaped cells (opaque) 
[23]. The strains can revert from white colony to opaque colony and contribute to its 
virulence. White phase cells are more virulent in invasive infection, and opaque 
phase cells are better to colonize skin [23, 53]. Phenotypic switching also affects 
other virulence traits, including the bud hypha transition, sensitivity to neutrophils 
and oxidants, antigenicity, adhesion, secretion of proteinase, drug susceptibility, and 
phagocytosis by macrophages [53].  
1.3. Molecular epidemiology of Candida spp. 
 Most Candida species belong to the Candida clade, exception of C. 
glabrata, which is more closely related to S. cerevisiae than to other Candida 
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species [59, 60]. C. albicans genome consists of eight pair of chromosomal 
homologs [61], ranging in size from 0.95 to 3.3 Mb in size and comprising 16 Mb 
in total. This species is predominantly diploid, however it exhibits a high degree of 
genome plasticity and exhibits frequent losses of heterozygosity as well as gross 
chromosomal rearrangements that may result in aneuploidy. Althought a 
reproduction is predominantly clonal, this species can also utilise a parasexual cycle 
involving the formation of tetraploid progeny from the mating of diploid parents, 
the former of which  subsequently revert to diploidy by concerted chromosome loss 
[62]. The parasexual cycle occurs rarely in nature, possibly only under stressful 
conditions. The main function of the parasexual cycle is thought to enable 
diversification during times of stress, revealing new combinations of recessive traits 
by loss of heterozygosity (LOH), or resulting in aneuploidy and copy number 
variation enabling adaptation to adverse environmental conditions. Aneuploidy and 
revelation of recessive alleles may adversely alter the fitness of the organism, but in 
highly stressful conditions the parasexual cycle may be a significant source of 
diversity permitting adaptation and survival of the organism [63, 64]. 
 Molecular epidemiology that combines traditional epidemiological 
investigation with molecular typing is useful for identifying community or 
nosocomial infections and tracing the source of transmission and outbreaks. 
Nowadays, several different molecular typing approaches including pulsed field gel 
electrophoresis (PFGE), restriction fragment length polymorphism(RFLP), random 
amplified fragment length polymorphism (RAPD), and multi locus sequence typing 
(MLST) [65]. Among these techniques, assays based on PFGE, RFLP or RAPD are 
labor intensive and time consuming. Furthermore, the results of these methods are 
difficult to compare among laboratories. By contrast, MLST, as a relatively new 
tool based on DNA sequencing, exhibits high discriminatory power and 
reproducibility, which overcome the flaws of more subjective methods, making it 
possible to compare results among laboratories. Therefore, nowadays MLST is a 
good tool to study and understand Candida spp. epidemiology molecular. Online 
global databases for many microorganisms are currently available at www.mlst.net, 
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including data from epidemiological studies carried out worldwide. This permits 
global epidemiological and population analysis [61, 65, 66]. MLST apply not only 
for C. albicans but also for others species like C. glabrata, C. tropicalis, C. krusei, 
C. dubliniensi, C. parapsilopsis. 
A standard MLST protocol for molecular characterization of C. albicans has 
been proposed based on the sequences of seven housekeeping genes (AAT1a, 
ACC1, ADP1, MPI1b, SYA1, VPS13 and ZWF1b). This method has been widely 
used to study the population structure, transmission and microevolution of C. 
albicans. MLST studies have shown that this species‟infections often arise from an 
endogenous source and persistent C. albicans strains are maintained by hosts over 
prolonged periods of time, occasionally undergoing minor genetic variations known 
as micro variation [66]. Strain replacement has also been observed, as has the 
transmission of C. albicans isolates between different individuals and 
microvariation of persistent isolates occurring in the same individual between 
recurrent infections [61, 66]. 
Based on MLST, a total of 18 clades have been identified worldwide and 
these clades are associated with the geographic distribution of C. albicans [61, 67]. 
Clades have been defined as clusters of at least 10 isolates with DSTs that have a p-
distance below 0.04, while their p-distance with DSTs outside the clade is above 
0.04.  MLST clade 1 appears to have a global distribution, this clade represents 33% 
of UK isolates, 31% of isolates from elsewhere in Europe, 32% of isolates from 
southeast Asia and Japan, 28% of isolates from Australasia, 34% of isolates from 
the Middle East, 44% of isolates from South America and 49% of isolates from 
North America, 16% among isolates from Africa [61]. Other clades tend towards 
greater geographical specificity, though none are found exclusively within specific 
geographical limits: clade 2 is enriched with isolates recovered from the UK, clade 
4 is enriched with isolates from the Middle East and Africa, clade 11 is enriched 
with isolates from continental Europe, and isolates recovered from the Pacific tend 
to cluster in clades 14 and 17 [61, 67]. Studies in several countries in Asia have 
demonstrated that the most common clade was clade1 [61, 68, 69]. Moreover, clade 
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6, clade 17 were the majority in China [69], while in South Korea were clade 4, 
clade 12 and hight rate (18.6%) belong to new clade [68]. Until now, there has not 
been any studies of Candida spp. MLST in Viet Nam, therefore one is necessary to 
understand the epidiomology of Candida spp. in Asia as well as all over the world. 
Molecular strain typing also demonstrate that certain types are more 
commonly associated with invasive disease than others. Analysis of the largest 
database from MLST research, did not demonstrate any statistically valid 
differential subset of strain types associated with disseminated infection [70]. 
However, there was a significantly greater proportion of isolates associated with 
superficial infections and commensal carriage in clade 1 versus other clades [70]. 
The obvious interpretation of this finding is that clade 1 isolates may be better 
adapted than others to colonize and invade epithelial surfaces, but have no inherent 
advantage over other types when it comes to traversing epithelia to cause deep 
tissue disease [61]. In addition, association between clade and the lengths of tandem 
repeats in some cell surface proteins (ALS) but not with virulence or type of 
infection, have been demonstrated [61] 
Most individuals carry a single C. albicans strain type, but minor variations 
suggestive of microadaptation are commonly observed. Some evidence suggests 
many individuals harbor a mixture of strain types that includes a range of minor 
variants, typically differing in levels of genetic heterozygosity [61, 66].  
Although most Candida infections appear to originate from an endogenous 
source, nosocomial transmission is not uncommon and may occur either by cross 
infection or by exposure to a common infecting source [61, 71, 72]. 
1.4. Molecular mechanism to resistant drugs in Candida spp. 
 The frequency of resistance to antifungal therapy continues to increase 
despite the introduction of new antifungal agents. Pathogen fungi have developed 
some mechanisms to survive in toxic environment. According to the literature, the 
following molecular mechanisms of drug resistance include: modification of the 
drug target affinity, overproduction of the enzymes that are targets to drugs, 
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development of alternative metabolic pathways, active efflux of the drug from the 
cell, impermeability of the cell membrane to drug molecules, active enzymes 
inactive the drug or degrading it outside the fungal cell [73-75]. Antifungal 
resistance is associated with elevated minimum inhibitory concentrations, poorer 
clinical outcomes, and breakthrough infections during antifungal treatment and 
prophylaxis. 
 Currently, there are two independent standards for broth microdilution 
(BMD) susceptibility testing of Candida and filamentous fungi: the Clinical and 
Laboratory Standards Institute (CLSI) method and the European Committee on 
Antimicrobial Susceptibility Testing (EUCAST) method. These methods are similar 
in that both use BMD, although there are some differences in inoculum size and 
MIC endpoint determination. These methods have been harmonized so that there is 
close agreement between MIC results obtained when testing azoles and 
echinocandins against Candida. The CLSI has also developed agar based, disk 
diffusion testing for yeasts. Compared with the BMD method, disk diffusion testing 
is convenient, simple, and economical, and is particularly well suited for water 
soluble antifungals such as 5-fluorocystosine, fluconazole, and voriconazole. Disk 
diffusion testing has been standardized for checking resistance of Candida spp. to 
fluconazole, voriconazole, caspofungine, micafungin, and break points have been 
provided for each of these agents [76]. 
 Various mechanisms can lead to resistance of Candida spp. to antifungal 
compounds. For azole drugs, the most common mechanism include the efflux 
pumps encoded by the mdr or cdr genes, and  point mutations in the gene encoding 
for the target enzyme ERG11 [76-81]. These mechanisms are shown in Figure 1.7. 
Resistance to amphotericine B is related to qualitative or quantitative changes in 
ergosterol by expression of mutations in erg3, erg6, erg11 genes [82]. Resistance 
mechanism of Candida sp. to echinocandins is typically caused by the fks1 genes 
encoding the major subunit of its target enzyme [75, 82, 83].  
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Figure 1.7. Main mechanisms of azole and polyens resistance [78] 
 Among antifungal drug, azoles are a class of antifungals that are widely used 
to treat both superficial mucosal and deep and disseminated fungal infections 
caused by C. albicans [77]. However, extensive use may lead to the development of 
resistance, resulting in therapeutic failure for Candida spp. [78]. In azole 
compounds, fluconazole is the antifungal agent of choice in the treatment and 
prophylaxis of infection by C. albicans [78, 84]. In addition, the emergence of 
fluconazole resistant C. albicans strains is a significant problem after long time use 
as the treatment for recurrent oropharyngeal candidiasis in acquired 
immunodeficiency syndrome (AIDS) patients  [78, 80]. Physicans encounter a high 
prvelance of fluconazole-resistant Candida, which makes the treatment of 
candidemia a huge challenge [35]. Data from many coutries all over the world have 
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1.5. Candida spp. and bacteria interaction 
   The origin of bacterial life predates the appearance of eukaryotic organisms 
by more than two billion years. Therefore for bacteria, symbiosis with eukaryotes 
regardless of whether the outcome is negative, positive, or neutral for the organisms 
united through the interaction is a derived lifestyle [87]. Research in the interaction 
between bacteria and fungi has developed significantly in both breadth and depth in 
recent years. Bacterial fungal interactions (BFIs) are antagonistic, cooperative, 
synergistic, commensal, and symbiotic [88]. It has been reported that the most 
common BFIs are ones where the bacterial partner exploits resources from the 
associated fungus through a parasitic or commensalism interaction, although there 
are intriguing examples where the fungus is able to take advantage of bacterial 
resources in mutualistic interactions [87].   
Humans are naturally colonized by fungi and bacteria in a variety of niches, 
including the skin, the oral cavity, and the respiratory, digestive, and genital tracts 
[89]. In healthy individuals, these microorganisms are commensal and in some 
cases even beneficial to human health. By contrast, in immunocompromised 
patients, pathogenic fungi and bacteria represent a serious threat to their health. 
There are some studies reported that bacteria and fungi have been found together in 
infections of human burn wounds and keratitis [90-92]. Moreover, the forming of 
mixed communities between bacteria and fungi makes them more virulent and 
resistant to antibiotic therapies [93, 94]. Therefore, an understanding of the 
functioning of BFIs, particularily the development of strains related to resistance to 
drug therapies, in human health is an emerging and important challenge for medical 
researchers [95]. 
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Figure 1.8. The bacteria fungal interaction: the combination of physical 
associations and molecular interactions [88] 
 Observation of the effects of fungi on bacterial development is difficult due 
to the small size and single cellular nature of bacteria. However, if consideration is 
given to bacterial fungal biofilms, it is clear that fungi can promote distinct 
differences in bacterial development by contributing to a distinctive ecological 
niche, within which bacteria exhibit physiological differences, such as resistance to 
antibiotics, stress, and an altered expression of virulence genes, compared to free 
living bacteria [95, 96]. 
Recently, several studies have described the association of Candida spp. and 
bacteria, such as Staphylococcus aureus, Pseudomona aerugirosa, Staphylococcus 
epidermidis, ect. [93, 94]. 
 Helicobacter pylori (H. pylori) is a Gram negative, spiral shaped bacterium 
that infects more than 50% of the human population and can cause gastritis, peptic 
ulcer, or gastric malignancies [97]. It is necessary to understand H. pylori 
transmission to prevent this disease. The oral cavity has been hypothesized as a 
reservoir for gastric H. pylori, which has been detected by culture and with PCR in 
both dental plaque and saliva. Some researchers have proposed H. pylori in oral 
cavity may play an important role in its transmission and reinfection. Oral-oral or 
fecal-oral transmission are thought to be the most possible means of transmission [97].  
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H. pylori is generally considered an extracellular microorganism. However, 
there have been some evidences supporting a hypothesis that H. pylori 
microorganisms have an intracellular location [98, 99]. These findings support the 
hypothesis that this bacteria can invade fungi and survive from stressful 
environments. Normally, Candida spp. can also colonize in the gastric regions [91] 
and  invade epithelium cells in certain conditions [100]. Recently, some studies 
focused on the relationshop between the microrganism. Evidence has been 
suggested to show that Candida vacuoles can be a niche for H. pilory and and H. 
pylori specific genes, such as vacA, ureA and peroxiredoxin were detected by PCR 
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2. RESEARCH OBJECTIVES 
Candida species are normally associated with human beings as harmless 
commensals. They are commonly found on the mucosal surfaces of gastrointestinal 
and genitourinary tracts and skin of humans [5]. Candida spp. infect billions of 
people every year all over the world, causing a broad spectrum of infections, 
ranging from mucosal or localized cutaneous infections to systemic or potentially 
fatal diseases [36, 40]. To date, the incidence of invasive fungal diseases by 
Candida spp. is rising as a result of immunocompromised  patients,  modern 
medical interventions and therapies. For example, AIDS patients or who have 
undergone transplants generally receive immunosuppressive drugs or aggressive 
regimens of chemotherapy in cancer, respectively. Patients under these conditions 
are prone to mycosis, a majority of which are caused by Candida spp [40]. Systemic 
mycosis often requires high associated costs, particulary mycosis caused by 
Candida species which are less senstive to antifungal therapy  [76, 102]. Therefore, 
a better understanding of the epidemiologic features and etiology of candidose will 
enable physicians to provide better management strategies, preventitive measures, 
and treatment to infections.  
For many years, fungal laboratory methods based on the detection of 
phenotypic characteristics, such as microscopy and in vitro culture, have played an 
essential role in fungal etiology identification. However, these procedures are 
generally slow or non-specific. Furthermore, phenotypic features can be easily 
influenced by external factors such as variations in temperature, medium, and 
chemotherapy, making species identification difficult. Recently, genotypic 
approaches have proven to be useful for fungal identification. In fact, genotypic 
differences are considered more stable and precise than phenotypic differences. 
Molecular biology techniques, such as PCR, amplicon sequencing, MLST and 
MALDI-TOF MS, are useful in the identification and investigation of pathogenic 
fungi [103], particularly Candida species [104, 105].  
Ngo Thi Minh Chau – Application molecular techniques to study the etiology and epidemiology of Candida spp. 
infections in Central VietNam – Doctorate Thesis of Ph.D School in Biomolecular and Biotechnological Sciences, 
University of Sassari 
28 
In Vietnam, Candida superficial infections are common. Recently, invasive 
fungal infections have become more frequent due to the growing number of 
immunocompromised and other susceptible individuals in the population [106-109]. 
Although physicians have been faced with managing more of these infections, there 
has been a lack of systematic epidemiological data in this field [108, 110, 111]. In 
addition, the current gold standard techniques for the indentification of mycoses are 
direct examination and in vitro culture [112]. The use of of molecular techniques in 
the study of etiology and epidemiology of Candida spp. infections in Central 
Vietnam will be essential, useful and realistic. Furthermore, molecular techniques 
will allow for a more accurate overview of Candida molecular epidemiology and 
Candida causatives in Vietnam.  
For these reasons, the aims of this research are as follow: 
2.1. To study candidiasis etiology 
- Application of molecular techniques (e.g. Matrix Assisted Laser Desorption 
Ionization Time-of-Flight Mass Spectrometry and Internal transcribed spacer 
sequencing) in the identification of Candida species.  
- Analysis of the distribution of Candida species in candida colonization and 
candidiasis.  
2.2. To analyze the phenotypic and genotypic features of Candida spp. isolates 
-  Checking  antifungal susceptibility tests by disk diffusion method. 
- Detecting and analyzing polimorfism of resistance genes linked to 
fluconazole resistance in Candida tropicalis by PCR and sequencing (mutations in 
ERG11 gene). 
- Detecting virulence genes by Multiplex PCR (als1, hwp1, sap4). 
- Studying molecular typing of selected isolates of Candida albicans by 
Multi Locus Sequence Typing (MLST). 
2.3. To analyze relationship between Candida spp. and Helicobacter pylori  
Testing for the presence of Helicobacter pylori specific gene by nested PCR  
in Candida isolates 
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3. MATERIALS AND METHODS 
3.1. Study site 
This cross sectional study was carried out from October 2012 to August 2015 
at two Vietnamese  Hospitals, Hue University of Medicine and Pharmacy  Hospital 
and Hue Central Hospital, and the Biomedical Science Department at the University 
of Sassari in Italy. 
Samples were collected in 10 departments at Hue University of Medicine and 
Pharmacy Hospital (Dermatology, Endoscopy, Intensive Care, Internal Medicine, 
Obstetric, Oncology, Ophthalmology, Otorhinolaryngology, Pediatric and Surgery) 
and 2 departments at Hue Central  Hospital (Hematology and Pediatric).  
Direct examination, fungal cultivation, and fungal phenotype identification 
were carried out in Vietnam at the Parasitology laboratory at the Hue Medicine and 
Pharmacy University. Fungal genotype was conducted at the Carlo Urbani Centre  
in Hue, Vietnam and at the Microbiology laboratory, Department Biomedical 
Science in Sassari, Italy. 
3.2. Study population 
All patients were subsequently  divided into four groups. The first group 
included patients with candida colonization. These patients had Candida spp. 
isolated from unsterile body sites by both direct examination and culture but that did 
not display any symptoms related to superficial candidiasis or invasive candidiasis. 
These patients, furthermore, recovered without assistant from antifungal therapy. 
The second group was mucosal candidiasis. These patients displayed symptoms of 
the disease (oral candidiasis, vulvovagiginite candidiasis) and were clinically 
identified by doctors. In this case, Candida spp. was isolated by both direct 
examination and culture. Cutaneous candidiasis was the third group of patients. 
These patients had symptoms including parochynia, onychomycosis, and skin 
candidiasis. Candida spp. in these patients were isolated by both direct examination 
and culture. The fourth group was systemic candidiasis (candidemia or invasive 
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candidiasis). These patients had clinical symptoms and Candida spp. was isolated 
from blood, tissue, sterile body sites by a combination of direct examination and 
culture or culture only. 
3.3. Sample collection and Candida strains isolates 
Samples were collected from 163 patients admitted in 10 different hospital 
wards at Hue University of Medicine and Pharmacy Hospital and 2 wards at Hue 
Centrel  Hospital (see Table 3.1) 




Hue University of Medicine and 
Pharmacy Hospital 
Internal medicine 26 
Obstetric 24 












Selected patients were required to not have received antifungal treatment with 
the last seven days in order to prevent false negative cases. One sample was collected 
from each patient, with the exception of the seven patients in the Intensive Care Unit 
(HUMP Hospital), three patients in the Hematology ward (HC Hospital), two patients 
in the Pediatrics ward (HC Hospital), and one patient in the Endoscopy ward (HUMP  
Hospital). In detail, for the seven patients in the Intensive Care Unit, two samples 
from two different body sites were collected for 6 patients and three samples from 
three different body sites for 1 patient. For the three patients in Hematology ward, the 
two patients in the Pediatrics ward, and the one patient in the  Endoscopy ward, two 
samples isolated from two different body sites were collected. For the two patients in 
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the Pediatrics ward, two samples isolated from two different body sites. In total, 177 
samples from 163 patetients were used in the study. 
Specimens had been collected according to the patient‟s symptoms in 
primary candidiasis patients. By contrast, in patients without candidiasis, we 
detected Candida colonization status from oral, sputum, urine, gastric drainage 
fluid, gastric biopsy, bronchoalveolar lavage fluid, endotracheal aspiration fluid. 
Samples were collected from patients based on type of disease. Samples 
from mucosal (oral, vaginal, nasal) and skin lesions were obtained using sterile 
swabs [113-115]. Gastric biopsy was collected by endoscopy. Sputum and stool 
were collected into wide-mouthed sterile container [10]. From lower respiratory 
tract, bronchoalveolar lavage, endotracheal aspiration fluid were collected in 
volumes of 1 -5 ml [116]. Urine was isolated from midstream with volume from 10 
ml to 15 ml. For patients with catheters, urine was obtained by clamp of Foley‟s 
catheter distally [114]. Nail scrapings were collected in case of onychomycosis. 
Gastric fluid was removed from drainage in volumes of 10 -15 ml. A volume of 10 -
20 ml blood was collected from adult patients; for pediatric patients, the volume 
was 4-10 ml [41, 42, 114, 117, 118]. 
When necessary, oral, vaginal, skin lesion, and gastric biopsy samples were 
placed in distilled water and transferred to the laboratory. Urine and other body 
fluids were processed  by centrifuging at 2500g for 10 minutes before microscopy.  
Each sample was examined microscopically with 20% KOH to detect fungal 
morphological forms (budding yeast or/and hyphae) [10, 53]. The samples were 
then processed for fungal culture. 
Each specimen was inoculated first on Sabouraud dextrose agar (SAD) with 
chloramphenicol for 24 - 48h at 35
0
C [10, 114]. Candida colonies were sub cultured  
several times to purify strains. All isolates were stored at - 80
0
C in 15% glycerol 
[119] for future antifungal susceptibility tests and identification using molecular 
biology methods. 
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3.4. Candida spp. identification 
3.4.1. Phenotypic identification 
All Candida strains isolated from colony in SAD medium were sub-cultured in 
Brilliance Candida agar (Oxoid) and incubated aerobically at 30°C. The plates were 
checked at 24, 48 and 72 hours. Brilliance Candida agar was used for  differentiating 
among species of Candida since they produced different colored colonies [43]. The 
precense of two chromogens  in this medium (5-bromo-4-chloro-3-indolyl N acetyl ß-
D-glucosaminide and 5-bromo-6-chloro-3-indolyl phosphate p-toluidine salt) helped in 
identify for the presence of  two target enzymes, the hexosaminidase and the alkaline 
phosphatase, respectively. The precense of either enzymes allows for the differentiation 
of C. albicans and C. tropicalis  from other species of Candida  within 48 hours. The 
green colour of C. albicans and C. dubliniensis is caused by the same chromogenic 
reaction as well as the dark blue color of C. tropicalis. For others species, it is quite 
difficult to differentiate based on color. For example, the colors of C. glabrata, C. 
kefyr, C. parapsilosis, C. lusitanae could  be beige,  yellow or brown. Moreover, this 
medium can help recognize mixed strains showing different color, that could not be 
achieved by culture on SAD medium [44]. Based on culturing using Brilliance 
Candida agar medium, we had 16 sample with mixed strains (15 samples having 2 
strains and 2 samples having 3 strains). Therefore, in this study 196 Candida strains 
were isolated from 177 collected samples. 
 
Figure 3.1.  Colonies of C. albicans  and C. glabrata on Brillant Candida medium 
                               (http://www.oxoid.com/UK) 
( C. albicans: green colonies and C. glabrata: yellow colonies) 
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We also performed germ tube tests and chlamydospore assays to identify 
certain species, such as C. albicans and C. dubliniensis [10, 114]. For the germ tube 
assays, yeast was inoculated in 0.5ml-1 ml of human sera and incubated aerobically 
at 37
0
C for 3-4 hours [10]. A drop of the yeast-human serum mixture was examined 
microscopically and the appearance of small filaments projecting from the yeast cell 
surface indicates that the germ tube test was positive. In the chlamydospore assays, 
yeast cells were plated onto Cornmeal agar under a glass coverslip to maintain a 




Figure 3.2. Possitive germ tube test and chlamydospore assay  [10] 
3.4.2. Genotypic identification 
 We applied Matrix Assisted Laser Desorption/Ionization Time of Flight 
Mass Spectrometry (MALDI-TOF MS) to identify Candida species. MALDI-TOF 
MS is a type of mass spectrometry that measures the time of travel of ionized 
peptides. This method is used for rapid and reliable microbial identification. For this 
technique, the sample is first absorbed onto a matrix then bombarded with a laser 
beam. After irradiation, the matrix vaporizes and the sample is left with an electrical 
charge (ionization). Ions are accelerated by an electric field of known intensity. The 
acceleration of the ions occurs within a drift tube at constant kinetic energy. Since 
the speed of the ionized particles is inversely related mass, it follows that lighter 
ions will reach the detector first. The output measurement is  the  time it takes for a 
particular particle to reach the detector at a known distance. The ions separate 
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according to their mass-charge ratio (m / z) and the amount of each ion is measured. 
The detection is performed at the end of the flight tube. The spectrum generated is 
analyzed as an individual proteomic profile with the molecular mass ranging from 
2000 to 20000 Da. The Principle of MALDI-TOF Mass Spectrometry system is 
described in Figure 3.3. 
 
Figure 3.3. Principle of MALDI-TOF Mass Spectrometry system [120] 
This technique is able to differentiate bewteen closely related species, such 
as C. glabrata from C. bracarensis, C. albicans from C. dubliniensis, and C. 
metapsilosis and C. orthopsilosis from C. parapsilosis. 
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 Fungi were subcultured in SAD plates from strains stored in 15% glycerol at 
- 80
0
C. Affter 24h incubation, they  were used for identification with  MALDI-TOF 
MS. A small amount of sample from a single colony was picked by a sterile tip and 
transferred directly and spotted in duplicate onto the MALDI target (MSP 96 target 
polished steel plate; Bruker Daltonik MALDI Biotyper) and air-dried at room 
temperature. Next, 1μl pure ethanol was added to each well to fix the sample. 
Aliquots of 1 µl of 70% formic acid were added and mixed gently with the yeasts. 
When the liquid medium was almost evaporated, each spot was overlaid with 1 μl 
of HCCA (a-cyano-4-hydroxy cinnamic acid) matrix solution and left at room 
temperature to dry completely before MALDI-TOF MS measurement. Next, the 
loaded plate was analyzed by MALDI Biotyper CA System. The spectrum of each 
isolate was compared with those in the database and the identification was provided 
by score of reliability. Identification was provided with accompanying scores as the 
manufacturer‟s schemes: score <1.7: no reliable identity; score from 1.7-<2.0: 
identity at genus level; score from 2.0 to upper: identity at species level. This 
procedure was conducted in Microbiology Department, Nuoro  Hospital, Italy.  
Strains that had a score under 1.7 by MALDI-TOF MS were further 
identified  by PCR and sequence analysis using specific primers directed against the 
internal transcribed spacer (ITS) region.  
DNA isolation 
The total DNA was isolated using the thermolysis method according to the 
protocol of Zang et al [121]. All purified strains were removed from storage and 
placed on SDA plates at 25
0
C and incubated for 24h to allow for growth of single 
colonies. Next, a 1µl loop was used to transfer a small amount of yeast cells from 
the colony into 100 µl of sterilized water in a 1.5ml micro centrifuge tube to wash 
the cells. The mixture was vortexed thoroughly and then centrifuged at              
8.000-10.000g for 1 min. After carefully discarding the supernatant using a pipette 
tip, 100 µl of lysis solution was added to the pellet. The mixture was finally 
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incubated at 85 
0
C in a water bath for 30 min. The crude extract containing genomic 
DNA was stored at - 20 
0
C until use. 
The ingredients of the lysis solution, which was referred to as the breaking 
buffer, contained 50 mmol l
-1
 sodium phosphate at pH 7.4, 1 mmol l
-1
EDTA and 5% 
glycerol. Before use, the lysis solution was autoclaved at 121
0
C for 20 min and then 
stored at 4
0
C [121].  
Internal Transcribed Spacer PCR assay 
The  internal transcribed spacer (ITS)  regions  have  important  play of 
ribosom RNA (rRNA) processing in Eukaryotype [122].  They  form  specific 
secondary structures they are needed for correct recognition of cleavage sites and 
provide the binding sites  for  nucleolar  proteins  and  RNAs during  ribosome 
maturation. Therefore, rDNA genes have been used to identify pathogenic fungal 
disease. ITS primers amplify a targeted region of the ribosomal DNA of fungi 
[123]. In this study, internal transcribed spacer regions were amplified by using the 
following primers: 
ITS1 (5‟-TCCGTAGGTGAACCTGCGG-3‟)  
ITS2 (5‟-GCTGCGTTCTTCATCGATGC-3‟)  
All primers used in the present study were synthesized by Invitrogen (USA). 
PCR reactions were performed in a 25 µl volume with 2.5 µl of  10x PCR 
reaction buffer, 0.2 mmol/l of each of the four dNTPs, 1.5 mmol/l MgCl2 , 0.2 
µmol/l of each primer, 1 µl extracted DNA, 1.25 U Taq polymerase and sterile 
ultrapure water (all chemicals from Invitrogen, USA). Negative control was 
performed with sterile deionizer water in place of template DNA. 
Amplification procedure was performed in a thermal cycler (Hybaid, UK) 
with an initial denaturation in 5 min at 95
0
C, then followed 30 cycles: 1 minute at 
95
0
C for denaturation step, 1 minute at 56
0
C for annealing step, 1 minute at 72
0
C   
for  extension step,  and in 7 minute at 72
0
C for final extension. The products were 
then separated in 1% agarose gel in TAE buffer 1x containing GelRed™  nucleic  
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acid  gel  stain,  Biotium  (1 µl  /100 ml  in TAE 1x), and viewed on a UV trans -
illuminator. The lengths of Candida spp. amplified fragments were confirmed by 
the bands under 300bp, with the exception of C. glabrata. 
The amplicons were then cut and purified by the DNA Clean and 
Concentrator 
TM 
-5 (ZYMORESEARCH, USA) columns, and quantified by bands 
comparison to low molecular mass ladder, and sent for sequence at Sequencing 
Service LMU Munich, Germany (http://www.gi.bio.lmu.de/sequencing). 
Sequencing results were analyzed by Geneious version 4.8.4 and were blast in 
GeneBank for species identification. A blast match result that is greater than 99% 
was considred to be a good match  (http://blast.ncbi.nlm.nih.gov/Blast.cg). 
3.5. Antifungal susceptibility testing 
Antifungal susceptibility testing by disk diffusion methods was performed 
according to CLSI guidelines (CLSI document M44-A) [124] and manufacturer's 
instructions. The media and antifungal disks used in the testing were from 
Liofilchem Laboratories, Italy. The standard medium used for disk diffusion test 
was Mueller-Hinton agar supplemented with 2% dextrose and 0.5 μg/ml methylene 
blue. Incorporation of methylene blue in the medium has been found to improve the 
yeast growth and provide sharp zones of inhibition for the azole group of drugs.  
The colonies were suspended in 5 ml of sterile 0.85% saline, and the 
turbidity was adjusted to yield 1×10 5 - 1×106 cells/ml (0.5 McFarland standard). 
Next, a sterile cotton swab was dipped into the suspension and rotated several times. 
Any excess fluid from the swab was removed by pressing firmly against the inside 
wall above the fluid level before dispensing suspension inoculated on the plate 
surface. The plates were dried for 3-5 min at room temperature in laminar hood. 
Then, antifungal disks were placed on the inoculated agar with a forceps, and the 
plates were incubated at 37
0
C. The zone of inhibition was recorded after 24 hours 
and 48 hours. Nystatin 100 unit/disk, fluconazole 10 μg/disk, itraconazole 8μg/disk, 
ketoconazole 10μg/disk, amphotericinB 20μg/disk, flucytosine 10μg/disk, 
clotrimazole 10μg/disk, posaconazole 5μg/disk, and voriconazole 1μg/disk were 
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used (all antifungal disks from Liofilchem Laboratory, Italy). The C. albicans strain 
ATCC 90028, C. parapsilosis ATCC 22019 and C. krusei ATCC 6258 were used as 
standard strains.  
Zone diameter interpretive standards for Antifungal Disk Diffusion 
Susceptibility Testing of Candida spp. are followed manufacturer‟ instructions 
(Liofilchem Laboratories) and are shown in detail in table below. 
Table 3.2. Zone diameter interpretive follow Liofilchem Laboratory's instructions 
Drug Code Potency 
Zone in diameter (mm) 
S I R 
Amphotericin  B AMB 10 µg ≥15 10-14 No zone 
Fluconazole FLU 25 µg ≥19 15-18 (DD) 14 
Flucytosine AFY 1 µg ≥20 12-19 ≤11 
Itraconazole ITC 8 µg >16 10-15 (DD) <9 
Ketoconazole KCA 15 µg >30 23-29 (DD) <22 
Clotrimazole CLO 50 µg ≥20 12-19 ≤11 
Voriconazole VRI 1 µg ≥17 14-16 ≤ 13 
Nystatin NY 100 UI ≥15 10-14 No zone 
Caspofungin CAS 5 µg ≥11  ≤10 
(S: Susceptible, DD: Dose dependent, I: intermediate, R: resistant)  
3.6. Detection Candida virulence genes by multiplex PCR and sequencing 
C. albicans and C. non albicans may have different genes according to 
virulent factors. As C. albicans is the most important pathogen in this genus, three 
significant virulent genes were investigated in this study. These included hwp1 (C. 
albicans hyphal wall protein 1 HWP1), sap4 (C. albicans secretory aspartyl 
proteinase SAP4), and als1 (C. albicans agglutinin-like sequence ALS1). DNA for 
multiplex PCR was extracted as described above. 
We designed primers for hwp1, als1, sap4 from reference genes, including 
U64206.1 C. albicans hyphal wall protein 1 (HWP1) gene-completed cds, 
XM_712961.1 C .albicans  secretory aspartyl proteinase SAP4p (SAP4) mRNA-
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completed cds and L25902 C.albicans agglutinin-like sequence (ALS1) gene –
completed cds 
Primers used for PCR were as follows: 
hwp1 5‟-TGCTCCAGCCACTGAAACACCA-3‟ 
   5‟-GGTTTCACCGGCAGGCATGGAT-3‟ 
sap4   5‟-TGCCGATGGTTCTGTTGCACAAGG-3‟ 
              5 -GAGTCCTGGTGGCTTCGTTGCT-3‟ 
 als1   5‟-ACCCAACTGTCACCACCACTGA- 3‟ 
                        5‟-TCACCAGGTGGAGCGGTAATGGT-3‟ 
 PCR was conducted as follow: 1 µl DNA was added to a 0.2 ml PCR tube 
containing 0.2 µmol each oligonucleotide primer mix, 0.2 µmol/l each of dNTPs, 
1.5 mmol/l MgCl2, 1 U Taq DNA polymerase and 10x buffer in a final volume of 
25 µL (all chemicals from Invitrogen, USA). Negative control was performed with 
sterile deionizer water in place of template DNA.  
The mixtures were incubated for 5 min at 95
0
C, followed by 30 cycles of 
amplification. Each cycle consisted of denaturation at 95
0
C for 30 seconds, 
annealing primer at 55
0
C for 40 seconds, and primer extension at 72°C for 30 
seconds, and then the mixtures were kept at 72
0
C for 10 minutes in a thermal cycler 
(Hybaid, UK). The products were then separated in 1% agarose gel in TAE buffer 
1x containing GelRed™  nucleic  acid  gel  stain,  Biotium  (1 µl  /100 ml  in TAE 
1x) and viewed on a UV trans illuminator. The lengths of amplicons fragment for 
hwp1, sap4 and als1 were 274bp, 158bp and 400bp respectively. Amplicon bands 
were cut from the gel, purified using the Zymoclean™ Gel DNA Recovery Kit 
(ZYMORESEARCH, USA), quantified and sent for sequencing 
(http://www.gi.bio.lmu.de/sequencing) as describe above. Sequencing results were 
blast in GeneBank (https://blast.ncbi.nlm.nih.gov) to confirm the genes identity 
with match score >99%. 
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3.7. Detection of erg11 gene mutations associated to fluconazole resistance in C. 
tropicalis  by PCR and sequencing  
 Azoles are the most common drugs using to treat fungal diseases, and the 
indiscriminate use of these drugs, especially fluconazole, has leaded to the 
emergence of resistance in Candida spp. Mutations in ERG 11 gene coding for 
lanosterol 14α-demethylase [76, 125], is the main molecular resistance mechanism 
to azole in Candida spp., so we decided to apply PCR and sequencing to detect 
possible polimorfism in ERG11 gene in 15 C. tropicalis resistant strains isolates. In 
addition, one sensitive strain isolate was include in the study and  use as control 
(Strain code number 144).   
 We designed two pairs of primers on erg11 reference gene (AY942645.1 
C. tropicalis strain IHEM 21234-lanosterol 14 alpha demethylase- completed gene). 
 Primers were as follows: 
 erg11a   Fwd 5‟-TCTTTTGTCAACACAGTAATGGC-3 
                  Rev -TGGATCAATATCACCGCTTTCTC-3  
 erg11 b  Fwd 5‟-GCGGTGATATTGATCCAAAGAG 
                  Rev- GGGATTTTTCTAGCTACTCCATGG 
Two separate PCR assays were performed to amplify the completed erg11 
gene. C. tropicalis DNA was extracted as previously described [121]. Each PCR 
reaction was done in a 25  µl volume with 12.5 µl of 2x PCR SuperMix, 0.2 µmol/l 
of each primer, and 1 µl extracted C. tropicalis DNA, and sterile ultrapure water (all 
chemicals from Invitrogen, USA). Negative controls were performed with sterile 
deionizer water in place of template DNA. 
Target  DNAs  were  amplified  in  a  thermal  cycler (Hybaid, UK). The 
amplication conditions  were as follows: initial  denaturation  at 94
0
C  for  5  
minutes,  then followed by 30 cycles, each cycle consisting of 30 seconds at 94
0
C 
for denaturation, 40 seconds at 50
0
C for annealing, and 50 secondes at 72
0
C for 
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elongation, and by a final elongation step of 10 minutes at 72
0
C. The products were 
then separated in 1% agarose gel in TAE buffer 1x containing GelRed™  nucleic  
acid  gel  stain,  Biotium (1 µl  /100 ml  in TAE 1x), and viewed on a UV trans 
illuminator. The bands for erg11a and erg11b were 834 bp and 816 bp respectively. 
PCR products were purified, quantified and sent for sequencing as described 
above. Sequencing was performed in both directions using forward and reverse 
primers to ensure complete gene sequencing. The obtained nucleotide sequences were 
analyzed using Geneious Pro 4.8.4, translated into amino acid sequences, aligned and 
compared with a ERG11 reference sequence (GenBank accession: C. tropicalis 
AY942645). The similarity values between Candida reference strains and GenBank 
sequence was 99%- 100%. The nucleotide changes found in the ERG11 sequences 
were characterized using the yeast differential genetic code for the CUN codon [126]. 
3.8. Candida albicans Multi Locus Sequence Typing 
Fifteen selected C. albicans strains isolates were typed by using an MLST. 
Strains were selected from different sources and different departments, including 
Internal medicine (n=2), Pediatric (n=2), ICU (n=2), Oncology (n=2), Hematology 
(n=2), Surgery (n=1), Dermatology (n=1), Obstetric (n=1), Ortohinolaryngology 
(n=1). 
The internal regions of seven housekeeping genes (AAT1a, ACC1, ADP1, 
MPIb, SYA1, VPS13, and ZWF1b) were amplified using specific sets of primers 
included in the C. albicans  MLST scheme (http://pubmlst.org/calbicans) and 
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Table 3.3. Primers of 7 housekeeping genes  (http://calbicans.mlst.net/) 





Aspartate aminotransferase 478 
ACC1F-5‟-GCAAGAGAAATTTTAATTCAATG-3‟ 
ACC1R5‟-TTCATCAACATCATCCAAGTG-3‟ 
Acetyl-coenzyme A  carboxylase 519 
ADP1F5‟-GAGCCAAGTATGAATGATTTG-3‟ 
ADP1R5‟-TTGATCAACAAACCCGATAAT-3‟ 
ATP-dependent permease 537 
MPIbF5‟-ACCAGAAATGGCCATTGC-3‟ 
MPIbR5‟-GCAGCCATGCATTCAATTAT-3‟ 
Mannose phosphate isomerase 486 
SYA1F5‟-AGAAGAATTGTTGCTGTTACTG-3‟ 
SYA1R5‟-GTTACCTTTACCACCAGCTTT-3‟ 
Alanyl-RNA synthetase 543 
SVP13F5‟-TCGTTGAGAGATATTCGACTT-3‟ 
SVP13R5‟-ACGGATGGATCTCCAGTCC-3‟ 






PCR was carried out in 25 µl reaction volume containing 12.5 µl 2x PCR 
SuperMix (Invitrogen), 0.4µmol/l primer mix and 1µl DNA extracted. The mixture 
was run in a thermal cycler (Hybaid, UK), by following protocol: initial 
denaturation at 95
0
C for 5 minutes, followed by 35 cycles consisting of 40 seconds 
at 95
0
C for denaturation, 40 seconds at 52
0
C for annealing, and 45 seconds at 72
0
C 
for elongation; then the mixtures were kept at 72
0
C for 10 minutes for final 
extension. The products were then separated in 1% agarose gel in TAE buffer 1x 
containing GelRed™  nucleic  acid  gel  stain,  Biotium  (1  µl  /100  ml  in TAE 
1x), and viewed on a UV trans illuminator. Purified amplicons (DNA Clean and 
Concentrator 
TM 
-5 (ZYMORESEARCH, USA) were sent for sequencing at LMU, 
Germany (http://www.gi.bio.lmu.de/sequencing).  
The obtained nucleotide sequences were trimmed and analyzed using 
Geneious Pro 4.8.4, and DSTs were assigned according to the C. albicans MLST 
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database (http://pubmlst.org/calbicans/). Each DST resulted from the combination 
of the genotypes obtained at the seven loci.  
The eBURSTv3 program (http://eburst.mlst.net/) was used to assign isolates 
to genetic complexes and to evaluate the genetic relationships of the DSTs. Isolates 
that did not cluster were labeled as singletons.  
3.9. Detection H. pylori from Candida spp. by nested PCR and sequencing 
Candida strains isolates from clinical samples were subculture five time on 
SAD agar with chloraphenicol and penicillin in order to leave out all H.pylori that 
can co-exist with Candida spp. from specimens before Candida DNA process as 
describe above.  
We used nested PCR to detect H. pylori DNA from the DNA extracted from 
all Candida spp.  
The specific H.pylori UreA gene was detected according with the protocol of 
Miyabayashi et al using  primers HP 64F 5‟-TCACCCCAAAAGAGTTAGAC-3‟ 
and HP 64R 5‟-GAAGTGTGAACCGATTTGAA-3‟(428bp)[127]. The second 
primers pair, HP UreA new F 5‟-GTGGAAGCGGTACGTTTGAT- 3‟ and HP 
UreA new R 5‟-TTCCTGATGGGACCAAACTC-3‟ (183 bp) were designed by 
this study using the first amplicons sequence as a template.  
In the first nested PCR step, a mixture was prepared in 0.2 ml PCR tube by 
add 2.5 µl of  10x PCR reaction buffer, 0.2 mmol/l of each of the four dNTPs, 1.5 
mmol/l MgCl2, 0.5 µmol/l of primer, 1 µl extracted DNA,  1.25 U Taq polymerase 
and sterile ultrapure water to have 25 µl final volume (all chemicals from 
Invitrogen, USA). DNA templates were replaced with sterile deionizer water in 
negative control and pure H. pylori DNA for the positive control. The first PCR 
conditions  was  as  follows:  at 96
0
C for 2 minutes, 40 amplification cycles of at 
95
0
C for  15 seconds, at 53
0
C  for 15 seconds and primer extension at 72
0
C for 30 
seconds; and then at 72
0
C for 10 minutes. 
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In the second nested PCR step, the first PCR product was amplified by HP 
UreA new primers  in 0,2 PCR tube containing 2.5 µl of  10x PCR reaction buffer, 
0.2 mmol/l of each of the four dNTPs, 1.5 mmol/l MgCl2, 0.4 µmol/l of primer, 1 
µl of the first PCR product used as a template, 1.25 U Taq polymerase and sterile 
ultrapure water. Total volume was adjusted to 25 µl. The second amplification 
procedure was performed with an initial denaturation (5 minutes, 95
0
C), 35 cycles 
of 15 seconds at 95
0
C,  15 seconds at 55
0
C for annealing temperatures of primer 
pair, 30 seconds at 72
0
C of primer extension, and a final extension (7 minutes, 
72
0
C) in a thermal cycler (Hybaid, UK). 
The UreA gene sizes of amplicons were determined using 1.5% agarose gel. 
Specific and nonspecific bands were cut from the gels and purified using a Gel 
DNA Recovery Kit (ZYMORESEARCH, USA). Purified bands from both first and 
second amplifications were sent for sequencing (LMU). Obtained sequences were 
blast with the GenBank database to confirm the precence of  H. pylori DNA. A 
result that had greater than  99% similarity  was considered to contain H. pylori. 
With Candida strains presenting H. pylori, we also did experiments to 
culture H. pylori from fungal broken cells by selected H. pylori specific medium, 
Columbia blood agar in anaerobic condition. Nested PCR also performed to detect 
H. pylori ureA gene from Candida strains were subculture from storage at -80
0
C. 
3.10. Data analysis 
Results were analyzed with Geneious 4.8.4, SPSS 15.0 and Medcal 13.1. A 
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4. RESULTS 
4.1. Study population and Candida spp. identification by MALDI-TOF MAS 
and ITS sequencing 
4.1.1. Population distribution by wards, age and gender 
Totally, 163 patients were enrolled during the study period October 2012 to 
August 2015. In Hue University of Medicine and Pharmacy Hospital, most of the 
patients came from the departments of Internal Medicine, Obstetric, Intensive Care, 
Dermatology, Surgery, Endoscopy, Oncology and Otorhinolaryngology. In 
addition, some rare candidiasis cases were investigated in and Pediatric and 
Ophthalmology wards. 18 patients from Hue Central Hospital conducted to this 
study came from Hematology and Pediatric wards. The age of the patients ranged 
from less than one month to 89 years. This study included more number of female 
patients than male (94 vs 69), and there was statistically significant difference in the 
distribution of patient isolates by gender (p=0.0078). 
The number, rate of patients in each hospital ward, age and gender are shown 
in Table 4.1. 
Table 4.1. Population distribution by wards, age and gender 
Hospital ward Number of patients Percentage 
Internal Medicine* 26 15.95 
Obstetric* 24 14.72 
Intensive care* 17 10.43 
Dermatology* 18 11.04 
Surgery* 17 10.43 
Endoscopy* 14 8.59 
Oncology* 13 7.98 
Hematology** 10 6.13 
Pediatric* 5 3.07 
Pediatric** 6 3.68 
Otorhinolaryngology* 11 6.75 
Ophthalmology* 2 1.23 
Total 163 100 
Age Mean:45 ± 25 yrs. Median: 45 yrs. 
Gender Male: 69 (42.33%) Female: 94 (57.67%) 
* Hue University of Medicine and Pharmacy  Hospital 
** Hue Central  Hospital 
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4.1.2. Distribution of samples source in hospital wards 
A total of 177 clinical samples were collected from 163 patients admitted  in 
Hue University of Medicine and Pharmacy Hospitals (145 patients) and Hue Central  
Hospital (18 patients). Distribution of samples source in 11 hospital wards is shown 
in Figure 4.1. From Internal Medicine ward, sputum (61.54%), stool (26.92%), 
bronchoalveolar lavage (3.85%), oral mucosa (3.85%), and urine (3.85 %) samples, 
were collected. All of 24 samples gathered from Obstetric ward were vaginal 
secretion (100%). At Dermatology ward, samples were nail (61.11%), skin lesions 
(22.22%) and oral mucosa (16.67%). At Intensive Care Unit, a high rate of 
endotracheal aspiration fluid samples (44%), the same rate of gastric drainage fluid 
and urine samples (20%), 8% of oral mucosa and 4% of both blood and sputum 
were collected. Specimens from Surgery ward were gastric drainage fluid (70.59%), 
peritoneal fluid (5.88%), skin wound (5.88%) and sputum (17.65%). From 
Endoscopy ward 80% were gastric biopsies and 20% were oral mucosa specimens. 
Oral mucosa and sputum represented 84.62% and 15.38%. of samples from 
Oncology unit. There were 38.46% oral mucosa and 61.54% urine samples from 
Hematology unit. Specimens from Pediatric ward were 53.85% for oral mucosa, 
30.77% for stool and 15.38% for urine at. At Otorhinolaryngology, source samples 
were external ear (54.55%), nasal mucosa (9.09%), and sinus (36.36%). We 
collected two cornea ulcer samples at Ophthalmology ward. 
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Figure 4.1. Distribution of samples sources by hospital ward 
(Absolute number of samples isolated is shown in each column) 
4.1.3. Candida species identification by MALDI TOF MS and ITS sequencing 
In total 196 Candida strains were isolated from 177 clinical samples, 94.9% 
of them were identified by MALDI-TOF (Matrix Assisted Laser Desorption 







































Blood (1) Bronchoalveolar lavage (1) Cornea ulcer (2)
Endotracheal aspiration fluid (11) Extranal ear (6) Gastric biopsy (3)
Gastric drainage fluid (17) Nail (11) Nasal mucosa (1)
Oral mucosa (41) Peritoneal fluid (1) Sinus (4)
Skin wound (5) Sputum (22) Stool (11)
Urine (16) Vaginal secretion (24)
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Ten Candida spp having score<1.7 were identidied by ITS sequencing  as  C. 
non albicans, including C. parapsilopsis (2 strains), C. orthosilopsis (1 strains), C. 
digboiensis (3 strains), C. famata (2 strains), C. mesorugosa (1 strains) and C. 
blankii (1 strains). Molecular identification details are shown in Figure 4.2 and 
Table 4.2. 
 
Figure 4.2. Candida identification result by MALDI -TOF MS and ITS sequence 
Table 4.2. Candida spp. identification 
Candida spp. Number of strain isolates Percentage 
    Candida albicans  94 47.96 
    Candida non albicans 102 52.04 
 C.tropicalis 32 16.33 
 C.glabrata 17 8.67 
 C.parapsilosis 21 10.71 
 C.orthopsilopsis 11 5.61 
 C.metapsilosis 3 1.53 
 C.krusei 7 3.57 
 C.guilliermondii 3 1.53 
 C.digboiensis 3 1.53 
 C.famata 2 1.02 
 C.mesorugosa 1 0.51 
 C.norgvebsis 1 0.51 
 C.blankii 1 0.51 
Although C. non albicans had high rate than C. albicans (52.04% vs 
47.96%), the incidence rate difference was not significant (p=0.567). 
94.9 
5.1 
MALDI TOF mass (186 strains)
PCR and sequence (10 strains)
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4.1.4. Distribution of Candida spp. in  hospital wards 
There was diversity in Candida species distribution in the wards, in 
particular in Internal Medicine, Dermatology, and Pediatric. Overall, C. albicans 
was the dominant species in almost all hospital wards, with the exception of 
Ophthalmology and Otorhinolaryngology 
 
Figure 4.3. Distribution Candida spp. in  hospital wards 


































































C.albicans C.tropicalis C.glabrata C.parapsilosis C.orthopsilosis
C.metapsilosis C.kru C.guilliermondii C.famata C.mesorugosa
C.norvegebsis C.digboiensis C.blankii
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4.1.5. Distribution of C. albicans and C. non albicans in candida colonization 
and candidiasis 
Patients status was classified in four groups depending on whether they 
showed candida colonization, cutaneous candidiasis, mucosal candidiasis, or system 
candidiasis. Patients with candida colonization (85 patients) were defined if 
Candida spp. were isolated from unsterile body sites (urine, sputum, stool, gastric, 
endotracheal aspiration, external ear, bronchoalveolar), they didn‟t have any 
symptom of candidiasis and they recovered without antifungal therapy. Mucosal 
candidiasis patients (73 patients) included oral candidiasis, vaginal candidiasis, 
nasal candidiasis, sinus candidiasis, cornea candidiasis. Onychomycosis and skin 
candidiasis patients belong to cutaneous candidiasis (20 patients). Systemic 
candidiasis (18 patients) included candidemia, peritoneal candidiasis, rhinosinusitis, 
pulmonary candidiasis.  There was a different significant presence of C. albicans 
and C. non albicans in colonization and mucosal candidiasis, with high proportion 
of C. non albicans in candida colonization (p value was 0.0186), and contrast of C. 
albicans in mucosal candidiasis (p value was 0.0019). The result is shown in figure 
below. 
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4.2. Phenotypic and genotypic characterization of Candida spp. isolates 
4.2.1.In vitro antifungal susceptibility testing 
Antifungal susceptibility of Candida spp. by CLSI disk diffusion method (n=178) 
Nine drugs testing by CLSI disk diffusion method were amphotericine B, 
nystatin, fluconazole, ketoconazole, clotrimazole, voriconazole, itraconazole, 5- 
fluorocystocine, and caspofungin. The percentage of resistance for each drug by 
Candida  spp is described in Table 4.3 
Table 4.3. Antifungal susceptibility test by disk diffusion  
Drugs Resistant (%) Intermediate (%) Susceptible (%) 
AmphotericinB 
(10µg/ml) 
0 8.99 91.01 
Nystatin (100UI/ml) 0 0 100 
Fluconazole (25µg/ml) 23.60 5.05 71.35 
Itraconazole (8µg/ml) 24.16 15.73 60.11 
Voriconazole (1µg/ml) 23.03 3.94 73.03 
Clotrimazole (50µg/ml) 2.25 3.37 94.38 
Ketoconazole (15µg/ml) 1.12 1.69 97.19 
5-Fluorocystocine 
(1µg/ml) 
19.66 5.06 75.28 
Caspofungin (5µg/ml) 10.67  89.33 
 
Trend of Polyene drugs resistance 
There wasn‟t any resistance to polyene group drugs in this study. 100% 
Candida strain isolates were sensitive to nystatin. The susceptible rate to 
amphotericine B was 91.09%. Some strains were intermediate for amphotericine B, 
including C. tropicalis (13.33%), C.parapsilosis 4.67%, C. krusei (50%), C. 





Ngo Thi Minh Chau – Application molecular techniques to study the etiology and epidemiology of Candida spp. 
infections in Central VietNam – Doctorate Thesis of Ph.D School in Biomolecular and Biotechnological Sciences, 
University of Sassari 
52 
Trend of azole resistance  
Table 4.4 show the frequency of Candida spp resistance to azole group drugs. 
Table 4.4. Frequency Candida species resistance to azole group drugs (%)  
Candida species 
(no of strains testing) 
Fluconazole Itraconazole Voriconazole Clotrimazole Ketoconazole 
C.albicans (83) 2.41 3.61 4.82 1.20 0 
C.tropicalias (30) 56.67 56.67 70 10.00 3.33 
C.glabrata (15) 6.67 53.33 26.67 0 6.67 
C.parapsilosis (21) 4.76 4.76 4.76 0 0 
C.orthosilosis (11) 90.91 81.82 63.64 0 0 
C.metasilosis (2) 50 0 0 0 0 
C.krusei (6) 100 66.67 66.67 0 0 
C.famata (2) 0 0 0 0 0 
C.norgvebsis (1) 0 0 0 0 0 
C.digboienis (3) 66.67 33.33 0 0 0 
C.blankii (1) 0 0 0 0 0 
C.guilliermondii (2) 50 0 0 0 0 
C.mesorugosa (1) 100 0 0 0 0 
Total (178) 42 43 41 4 2 
 Higher rate resistance to triazole (Fluconazole, itraconazole and voriconazole) 
than imidazole (Ketoconazole, clotrimazole) were found in C. tropicalis, C. 
orthopsilosis, C. krusei, C. digboiensis, C. guilliermondii and C. mesorugosa. 
There was also different level of resistance to at least one type of azole drug 
in C. albicans, C. tropicalis, C. glabrata, C. parapsilosis, C. orthopsilosis, C. 
metapsilosis, C. krusei, C. digboiensis, C. guilliermondii, C. mesorugosa. 
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Fluconazole  vs 
Itraconazole vs 
Voriconazole (%) 
C.glabrata  6.67 6.67 6.67 
C.krusei 66.67 66.67 66.67 
C.orthopsilosis  72.72 63.63 54.54 
C.tropicalis  50 46.66 53.33 
A significant resistance to the two out or the three azoles tested was found in 
C. tropicalis, C. krusei, C. orthopsilosis. 
Trend of 5-Fluorocytosine resistance 
In this study 5-Fluorocytosine resistance occurred in C. albicans 
(19.28%), C. tropicalis (16.67%), C. parapsilosis (19.05%) (Figure 4.6).  
Although C. krusei, C. norgvebsis and C. blankii showed  100% resistance to 
5-fluorocytosine, the small number of strains analyzed, to confirm the high 
resistance in these species, further study requires. 
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Trend of echinocandine resistance 
Among Candida species isolates, C. albicans had higher percentage 
resistance to caspofungine than C. tropicalis, C. parapsilosis, but  the difference is 
not statistically significant (p>0.05).  
 
Figure 4.7. Frequency Candida spp. resistance to caspofungin 
Multiple drugs resistance (MDR) 
In 178 strains checked for antifungal testing, one C. tropicalis strain was 
MDR. This strain was detected from urine of female patient 91 years old  
hospitalized at Intensive Care Unit by urine infection. Antifungal testing shown that 
this strain was resistant to fluconazole, itraconazole, voriconazole, 5-fluorocytosine 
and caspofungine. 
4.2.2. Mutations in ERG11 protein associated to fluconazole resistance of C. 
tropicalis 
We detected two mutations in the erg11 gene (A395T and C461T ), that 
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(Table 4.6 and Figure 4.8). The rate of these mutations was 26.67% among all C. 
tropicalis fluconazole resistant isolates.   
Table 4.6.  erg11 gene mutations in 15 C.tropicalis strains 
Strain code Nucleotide mutations Meaning 






      G1362R T2196Y 
Silent 
mutations 
5A T225Y G264R C639Y    G1362A T1554C 
Silent 
mutations 
38A T225Y G264R C639Y    G1362A T1554C 
Silent 
mutations 
39       G1365R T1554C 
Silent 
mutations 





 G1362A T1554C 
Missense  
Mutations 
58       G1362A T1554C 
Silent 
mutations 
66      T781A G1362R T2196Y 
Silent 
mutations 





 G1362A T1554C 
Missense  
mutations 
70 T225Y G264R     G1362A T1554C 
Silent 
mutations 
88 T225Y G264R C639Y    G1362A T1554C 
Silent 
mutations 
95       G1362R  
Silent 
mutations 





 G1362A T1554C 
Missense  
mutations 
114       G1362R T2196Y 
Silent 
mutations 
150       G1362R T2196Y 
Silent 
mutations 
152 T225Y G264R C639Y    G1362A T1554C 
Silent 
mutations 









Figure 4.8. ERG11 missense mutations in C. tropicalis strain no. 41 and no.189 
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Figure 4.9. ERG11 silent mutations in C. tropicalis strain no. 193 
4.2.3. Candida virulence genes (als1, hwp1, sap4) 
We performed multiplex PCR to detect the als1, hwp1, sap4 virulence genes 
presence in all Candida isolates. Overall, 96.8 % of C. albicans isolates carried all 3 
genes (Figure 4.10), regardless of the sample source. Some C. albicans isolated from 
vaginal secretion and endoscopic aspiration fluid didn‟t carry the als1 gene. None of 
these genes was amplified in other Candida spp. and none of the unspecific amplicons 










Figure 4.10. C. albicans virulent genes: sap4, hwp1 and als1 gene amplification 
products in positive samples 
 (sap4:158bp, hwp1: 274bp, als1: 400bp, M: molecular size markers) 
Virulence genes percentage in 94 C.albicans strains isolated from different 
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Table 4.7. Source of C. albicans strains detecting virulent genes 
Source n ALS1 (%) HWP1 (%) SAP4 (%) 
      Oral 30 100 100 100 
      Vaginal secretion 16 93.75 100 100 
       Sputum 12 100 100 100 
       Gastric drainage fluid 9 100 100 100 
       End. aspiration fluid 6 83.33 100 100 
       Urine 5 100 100 100 
       Stool 5 100 100 100 
       Nail 3 100 100 100 
       Skin wound 3 100 100 100 
       Gastric biopsy 1 100 100 100 
       External ear  1 0 0 100 
       Bronchoalveolar lavage 1 100 100 100 
       Peritoneal fluid 1 100 100 100 
       Sinus secretion 1 100 100 100 
Total 94 96.81 98.94 100 
4.2.4. Candida albicans Multi Locus Sequence Typing 
Table 4.8 shows DTSs assigned according to the C. albicans  MLST 
database (http://pubmlst.org/calbicans/)  
Table 4.8. The DST assignments at each of seven MLST loci for all 15 C. albicans isolates  
Strain code Unit Source AAT1a ACC1 ADP1 MPIb SYA1 VPS13 ZWP1b DST CC 
104 Oto Sinus 4 4 6 6 96 111 15 2932**  
26 Obs vaginal 4 4 6 6 96 111 15 2932**  
49 ICU Oral 5 4 6 3 93 189 22 2933**  
69 Hem Oral 5 5 5 27 2 6 146 2934**  
108 Onc Oral 5 5 5 4 2 6 5 2445 69 
89 ICU intertrachea 59 5 21 21 80 108 15 2937**  
60 Ped Oral 59 5 21 21 80 108 15 2937**  
17 Ped Stool 1 7 15 6 61 105 112 693 693 
19A Int med Sputum 4 17 21 19 27 83 22 299 299 
91 Int med Stool 4 17 21 19 27 13 22 459 299 
179 Sur Gastric 8 29 4 4 207* 279 266* 2936***  
5 Onc Oral 8 29 4 4 207* 279 266* 2936***  
75 Hem Oral 5 32 21 34 7 55 5 732  
120 End gastric 47 35 4 21 74 118 105 2477 1698 
32 Der skin wound 5 78 5 9 2 6 5 2935**  
(Oto: Otorhinolaryngology, Obs: Obstetric, ICU: Intensive Care Unit, Hem: 
Hematology, Onc: Oncology, Ped: Pediatric, Int med: Internal Medicine, Sur: 
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Surgery, End: Endoscopy, Der: Dermatology) 
* New allele detected from this study 
** New combination detected from this study 
*** New DSTs identified in this study. 
A total 54 variable loci were identified among 15 C. albicans clinical 
isolates, representing 1.83% (54/2.937) of the total nucleotides.  A total of 12 
diploid sequence types (DSTs) were identified from 10 different wards. Six were 
new DSTs, 5 of which (DTSs 2932, 2933, 2934, 2935 and DTS 2937) derived from 
new combination of alleles already present in database and 1 (DTS 2936) with two 
new alleles assigned us from MLST database (SYA1=207, ZWP1b=266).  
Loss of heterozygosity was observed in VPS13 sequences (Figure 4.11) 
obtained from two sequential isolates from two patients from Internal medicine 
wards (strain no.19A and no. 91).  
 
Figure 4.11. Loss of heterozygosity in loci VPS13 (W to A) in strain no. 19A  
gave origin to strain no. 91 
We detected the same DTS clone from different wards: DTS 2933 (Obstetric 
and Otorhinophagology), DTS 2936 (Surgery and Oncology), DTS 2937 (Intensive 
Care unit and Pediatric).  
E.Burst results 
MLST results were analyzed by eBURSTv.3 to assign isolates to genetic 
complexes and to evaluate the genetic relationships of the DSTs. Comparative 
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eBURST analysis of the 12 DTSs identified in this study, compared with the 2937 
C. albicans distinct DSTs presented in the MLST database (www.calbicans.mlst.net 
at the 30. 09. 2015) are showed in Figure 4.12. Results  showed that 2 clones (DST 
2445 and DST 2935) belong to the largest Clonal Cluster 1 (C1), a common CC 
reported from worldwide [61], based on DST 69 as the putative predictor founder. 
The DTS299 and  DST459, from which it derives for loss of homozygosis in the 
VPS13 gene, belong to C6, and DTS459 was previously isolated in China [69]. 
DST 723 belong to the C12 previously found in South Korea [68]. DST 693 
belonging to the C21 was previously reported in Taiwan and South Korea [128]. 
New  potential nosocomial clones DST 2937, DST2932 belong to the C14, C22, 
respectively with the respectively predicted founders DST 443 and DST 768 
isolated previously in China and Japan,  while the DST 2936 is a  singleton together 
with DTSs 2933, 2934 and 2477.  
 
Figure 4.12. Population snapshot of the 2973 C. albicans distinct DSTs currently in 
the MLST database (www.calbicans.mlst.net) defined using eBURSTv3. 
In the snapshot a single line joins DSTs that differ by only one of the seven 
loci. The putative founding DST of the clones founded in our hospital and the 
MLST clade (C) (defined by Odds et al., 2007; Shin et al., 2011) to which these 
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DST belongs are indicated beside each. Predicted Founder DSTs for all CC are 
indicated in blue, and founders of sub-groups are indicated in yellow. Pink circle 
represent DTS founded in our hospital and already present in database, green circle 
represent  new DTS derived from new allele combination while the encircled  one is 
a new DTS with 2 new alleles(SYA1=207, ZWP1b=266). Single black dots 
represent singletons.  
Other Phylogenetic analysis, unweighted-pair group method with arithmetic 
mean (UPGMA), from concatenated sequences of the 7 MLST alleles of the whole 
DSTs database clusterized DST into specific Clades, Table 4.9 show the Clades 
(deduced from  Odds et al 2007, Wang et al 2015 Shin et al 2011) to which 
correspond the specific Clonal Cluster obtained by E.burst in this study 
Table 4.9. Clades corresponding to the clonal Cluster by E.burst and UPGMA 
Strain Code Unit DST Eburst Clade 
32 Der 2935 C1 1 
108 Onc 2445 C1 1 
17 Ped 693 C21 3 
26 Obs 2932 C22 5 
104 Oto 2932 C22 5 
120 End 2477 SINGLETON 8 
19A Int med 299 C6 12 
91 Int med 459 C6 12 
89 ICU 2937 C14 17 
60 Ped 2937 C14 17 
49 ICU 2933 SINGLETON New 
5 Onc 2936 SINGLETON New 
179 Sur 2936 SINGLETON New 
69 Hem 2934 SINGLETON New 







Ngo Thi Minh Chau – Application molecular techniques to study the etiology and epidemiology of Candida spp. 
infections in Central VietNam – Doctorate Thesis of Ph.D School in Biomolecular and Biotechnological Sciences, 
University of Sassari 
61 
4.3. Detection H. pylori from Candida spp. by nested PCR and sequencing  
4.3.1. Presence  of H. pylori in Candida spp.  
Almost 15.27% of the Candida spp. tested for the presence of H.pylori ureaA 
specific gene  showed positivity at first or second step of nested PCR. Sequencing of 
specific bands obtained from the first and second PCR amplifications, and also of 
unspecific bands obtained from the second PCR amplifications (Figure 4.13 and 4.14) 
were identified as H. pylori by http://blast.ncbi.nlm.nih.gov/Blast.cgi (99%  identity 
with  H. pylori urease alpha subunit (ureA) strain  G27 Genebank AM997161)  










Figure 4.13. Detection of ureA gene (408bp) in first amplicons 
 
Figure 4.14. (1) Specific band (183bp) and (2) unspecific band (300 bp) 
 from second amplicons 
49   95     1    2     3    4      5      10    12   13     15   16   K+    M 
60  63     9b    14   19a  21   24    25   33a   26   29   45     K-    M 
2 
1 
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4.3.2. Distribution of Candida spp. in H. pylori DNA (+) 
In particular H. pylori DNA was amplified from three Candida species, 
including C. albicans, C. tropicalis and C. orthopsilosis. (Figure 4.15). 
Despite the higher H. pylori frequency, in  C. albicans compared the others 
species, this difference was not significant (p>0.05). In addition, in this study we 
didn‟t find any correlation between H. pylori presence and C. albicans virulence 
genes presence H. pylori was detected in Candida spp. isolated from gastric 
drainage fluid, oral mucosa and vaginal secretion. 
 
Figure 4.15. Candida spp. distribution in H. pylori presence 
Table 4.10. Sources of  samples used to detect H. pylori DNA 
Sample sources (number of strain) H. pylori (+) % 
Endotracheal aspiration fluid (11) 0 0 
Gastric biopsy (3) 0 0 
Gastric drainage fluid (17) 2 11.76 
Oral mucosa (43) 11 25.58 
Sputum (22) 5 22.73 
Stool (11) 0 0 
Vaginal secretion (24) 2 8.33 
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Regarding the two C. albicans nosocomial strains (DST 2936 as detected by 
MLST) only one positive for H. pylori (strain no.5 from Oncology, while strain 
no.179 from Surgery did not). 
 Additionally, our experiments showed that H. pylori could not be cultured 
from Candida broken cell by cultivation on Columbia blood agar in anaerobic 
condition and its Dna was degradable, expecially after storage period of Candida 
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5.  DISCUSSION 
During the  three year study period, 196 Candida spp. strains were isolated 
from 163 patients  that attended Hue University of Medicine and Pharmacy  
Hospital and Hue Central Hospital. 
5.1. Candida species identification by MALDI - TOF MS and ITS sequencing 
 In our study, 186 Candida strains isolates (94.9%) were identified by 
MALDI -TOF MAS. This result demonstrated reliability of this technique to 
identify yeasts from plate culture. In addition, this method was also able to 
discriminate between closed species (e.g. species in C. parapsilosis complex group 
or species in C. rugosa complex group), which cannot be differentiated by 
phenotypic identification [129]. Several previous studies have concluded that 
MALDI - TOF MS is a rapid and reliable technique to identify yeast species [105, 
130-132]. 
Although MALDI-TOF MS has been shown to discriminate between closely 
related Candida species by certain studies [130], such as C. parapsilosis, C. 
orthopsilosis and C. metapsilosis, other studies have shown that this method is not 
always reliable. For example, De Carolis et al showed that this method can not 
distinguish beetwen C. parapsilosis and C. orthopsilosis [133]. Pulcaro et al showed 
that MALDI-TOF MS was unrealiable for the identification C. glabrata and C. 
parapsilosis from bood culture [105]. The inability of this method to identify cetain 
species may be due to the limitation of the database. In other words, the database 
may not account for the biological variability of these yeasts, even for a single 
species. A more extensive database would help solve this problem [130]. By 
MALDI-TOF MS, a number of species had an indentification score that was less 
than 1.7 in the present study. These included C. parapsilosis, C. orthopsilosis, C. 
digboiensis, C. famata, C. mesorugosa, C. blankii. Follow-up identification was 
achieved by PCR and sequencing. In study by Mancini N. et al demonstrated that 
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MALDI TOF MS identification of Candida spp. isolates in human by Bruker 
Biotyper system could not identify C. blankii and C. orthopsilosis [134] 
 Regarding the distribution of Candida species in the present study,               
C. albicans was the dominant species (47.96%), followed by C. tropicalis 
(16.33%), C. parapsilosis (10.71%), C. glabrata (8.67%), C. orthopsilosis (5.61%), 
C. krusei (3.57%), C. guilliermondii  (1.53%), C. digboiensis (1.53%), C. 
mesorugosa (0.51%). C. norgvebsis (0.51%), and C. blankii (0.51%). Generally, the 
percentage of C. non albicans (52.04%) was higher than C. albicans (47.96%), but 
this difference was not significant (p  = 0.567). The five common pathogenic 
species in this study was similar to results from other studies [7, 135, 136]. 
Globally, the most frequently C. non albicans species in Northern Europe and the 
USA was C. glabrata[9], in Italy, Spain and Brazil was C. parapsilosis [9, 135], 
and in Asian countries was C. tropicalis [137].  Althought the proportion of C. 
tropicalis was higher than others C. non albicans species in Asian surveillance 
study, this species was more likely to be isolated from tropical countries than other 
Asian countries [137]. For example, an investigation by Mahmoudi R. et al in Iran 
about candidiasis, revealed that the percentage if C. albicans, C. glabrata, C. 
tropicalis, C. krusei, C. parapsilosis are 67%, 18.3%, 6.8%, 5.8%, 1.6%, 
respectively [136]. A study by Zang L. et al in China showed five common Candida 
species were  C. albicans (65.7%), C. glabrata (20.3%), C. tropicalis (8.8%),   (3%) 
and (1.4%) [85]. In the meanwhile, Boonyasiri A. et al reported four popular 
Candida species isolated from candidemia in Thailand including C. albicans (39%), 
C. tropicalis (28%), C.glabrata (22%) and C. parapsilosis (6%) [138]. Ding CH. et 
al determined that the four common species from candiurine in Malaysia were 
C. albicans (59.4%), C. tropicalis (28.1%), C. glabrata (9.4%) and C. parapsilosis 
(3.1%) [139]. A study by Tran et al in Vietnam (2010) indicated C. tropicalis was 
more popular than others species in C. non albicans group [106] Therefore, our 
result above suggested that Candida distribution in Vietnam is similar to Southeast 
Asian Nations with higher rate of C. tropicalis isolates than C. glabrata or C. 
parapsilosis. 
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Although C. albicans is the most common species in this genus, the rate of 
infections caused by C. non albicans species is increasing [140]. Results from the 
ARTEMIS DISK Global Antifungal Surveillance Study, occuring in 41 countries, 
showed  a decreasing rate of isolation of C. albicans (70.9% to 65.0%), while the 
number of isolates containg C. non albicans were increasing: C. glabrata (10.2% to 
11.7%), C. tropicalis (5.4% to 8.0%), and C. parapsilosis (4.8% to 5.6%) in time 
period 1997 - 2000 compared to 2005 - 2007 [7].  
Our study also showed a variety in Candida species distribution in the wards. 
For example, Internal Medicine, Dermatology, and Pediatric wards, each contain 8 
different species in total 11 species isolated. Overall, C. albicans was the 
predominant species in almost all hospital wards, with the exception of 
Ophthalmology and Otorhinolaryngology wards. 
In candida colonization and cutaneous candidiassis the percentage of C. non 
albicans were higher than C. albicans. In contrast, in mucosal and systemic 
diseases, more C. albicans were isolated than C. non albicans. It seems that C. 
albicans has more virulent and damaging in mucosal candidiassis and are more 
invasive than other species. Batista G.C et al indicated that C. albicans was the most 
common species in oral and could be the causitive agent of invasive candidiasis in 
neonatal patients [141]. In study by Deorukhkar S. C et al (2014), it was 
demonstrated that C. albicans expressed more biofilm formation, coagulase 
production, hemolysin production, phospholipase production, and proteinase 
production than C. non albicans [142], meanwhile an investigation by Udayalaxmi 
J. S and D'Souza D indicated that phospholipase production was better in C. 
albicans than compared to other species of Candida, and the difference in 
hemolysin and biofilm production between C. albicans and C. non albicans was not 
statistically significant [143]. 
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5.2. Phenotypic and genotypic characterization of Candida spp. isolates 
5.2.1. In vitro susceptibility testing 
 Antifungal susceptibility testing is required in antifungal therapy as well as 
in monitoring antifungal resistance. Many studies have reported an increasing 
number of resistant Candida spp. [7, 144, 145]. In the present study we followed 
CLSI disk diffusion method to testing antifungal resistance. Our results show that 
the percentage of Candida spp. that showed resistance to fluconazole, itraconazole, 
voriconazole, and 5-fluorocystocine were 23.60%, 24.16%, 23.03%, and 19.66%, 
respectively.  
 When examing resistant trends to azole drugs by species in this study, there 
was a higher rate  in C. non albicans than C. albicans (Table 4.4). This result is 
similar to other studies [146-148]. We recognized that C. non albicans was more 
resistant to triazole compounds (Fluconazole, itraconazole and voriconazole) than to 
imidazole (Ketoconazole and clotrimazole), which could be explained by the 
widespread use of fluconazole in prophylaxis for immunocompromised patients or 
for critical patients in Vietnam. Our study also observed a high rate in cross 
resistance for triazole group, especially in C. tropicalis, C. krusei and C. 
orthosilopsis. 
5.2.2. Mutations in ERG11 protein associated to fluconazole resistance of C. tropicalis 
C. tropicalis has increased dramatically in emerging pathogenic yeast, due to 
its developed resistance to fluconazole [149]. Overall, the rate of C. tropicalis is 
third to fourth highest among the most common species in Candida genus [85, 150] 
Meanwhile, some reports in the Asia-Pacific region concluded that it is actually the 
first or second most common isolated species [40, 149]. In addition, C. tropicalis is 
associated with the development of resistance to antifungal therapy, resulting in 
higher mortality compared to other Candida species [151] 
In our study, antifungal susceptibility testing for C. tropicalis showed strong 
resistance to fluconazole (56.67%). One mechanism of acquired resistance to azole 
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in C. tropicalis is caused by a mutation in the erg11 gene. Two mutations in the 
erg11 gene (A395T and C461T ) were determined in this present study, which 
corresponded to Y132F and S154F aminoacids substitution in the ERG11 protein. 
These missense mutations are associated to fluconazole resistance in C. tropicalis as 
previously described by other authors [152, 153] 
In total 15 strains of C. tropicalis, resistance to fluconazole were checked by 
indentifying mutations in ERG11 protein. The rate of missense mutations was found 
to be 26.67%. Mechanisms related to fluconazole resistance in other strains without 
protein mutations, could be associated with other mechanisms, such as overpression 
of this gene combine with mutations [125], or the upregulation of two multidrug 
efflux transporter genes, MDR1 and CDR1[153] 
5.2.3. Candida spp. virulence genes (als1, hwp1, sap4) 
 Three virulent genes (asl1, hwp1 and sap4) were checked for Candida 
isolates. The result showed that only C. albicans expressed these genes, and high 
proportion of C.  albicans isolates carried all 3 genes (96.8%). A study conducted 
by  Nas T. et al (2008) showed that the frequence of asl1, hwp1 and sap4 in 
C.albicans strains isolated from vaginitis in Turkey was detected as 69%, 62%, and 
38%, respectively [154]. Monroy-Perez E. et al determined the frequency of als1 
and hwp1 in C.albicans isolated from Mexican vaginal candidosis  and showed that 
the percent of strains having als1 and hwp1 were 100% ad 92%, respectively [155]. 
Various studies indicated C. albicans is often more virulent than other 
species [156-158]. As a consequence, higher rate of virulence factors in C. albicans 
than other species indicates that the virulence factors play a crucial role in the 
pathogenesis. This is help to explain why C. albicans was more isolates from 
mucosal candidiasis and systemic candidiasis in the current study as mentioned 
above.  
 An initial ability adheren to host tissue is one of the most mechamism to 
infection. Hwp1 and als genes play an important to adhenre host cells [23, 55]. The 
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als gene family encodes a cell surface protein that mediates adherence of C. 
albicans to endothelial cells [159]. The als gene family have different level 
expression in clinical samples. Als1, als2, als3, and als9 are most commonly 
expressed, followed by als6 and als7. The expression of als4 and als5 are the least 
common and usualy in clinical vaginal specimens [160]. Secreted aspartyl 
proteinase (SAP), an extracellular hydrolytic enzymes, is an another Candida spp. 
virulent factor. This enzymes contribute to host tissue invasion by digesting 
proteins, and it also plays in adhesion process. SAPs genes has been suggested to 
contribute to tissue invasion of C. albicans, particular sap 4-6 [161]. Furthermore, 
sap4-6 and hwp1 are combine expression in hyphae form as these genes are specific 
genes of this form [161], and ALSs genes in C. albicans tend to be located on 
chromosomes that also encode genes from the SAPs family [162]. However, als1 
gen likely relates to transform of germ tube to hyphae. In summary, C. albicans 
isolates in colonization or in candidiasis in this study possesed high proportion three 
virulent genes (als1, hwp1, sap4) reflecting that this species has strong virulence 
factors to become pathogen.   
5.2.4. Candida  albicans MLST 
 Multilocus sequence typing was used to characterize the genetic diversity 
and population structure of C. albicans isolated from two hospital in Central 
Vietnam. Multilocus sequence typing exhibiting high discriminatory power and 
reproducibility, is a  useful tool to identify community or nosocomial infections, 
tracing the source of transmission and outbreaks. Moreover, it is essential to have 
global surveillance in C. albicans MLST and for the comparison of genotypes in a 
central database accessed via the Internet http://pubmlst.org/calbicans/ enhancing 
global epidemiological knowledge. 
There was diversity in clonal comlpex in 15 C. albicans strains isolates with 
a total of 12 diploid sequence types (DSTs) identified from 10 different wards. 
Clade 1 (C1), recognized as the most prevalent C.albicans clade globally, is 
presented  13,3%  of our isolate (DST2445 and DST2935), DST 693 (C21) 
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belonging to the Clade 3 was previously reported in Taiwan and South Korea, 
DTS459(C6)  from Clade 12 was previously isolated in China,  DST 723 (C12) 
belonged to the new clade NCKorea, precisely previously found in South Korea,. 
New  potential nosocomial clones DST 2937 (C14), DST2932 (C22) belong to the  
Clade 17 and Clade 5 respectively with their predicted founders DST 443 and DST 
768 previously isolated in China and Japan.  DST 2936 is a  singleton together with 
DTSs 2933, 2934 and 2477. Summarizing 66.67% isolates clustered with 
previously known clades in global or Asian data, and 33.33% isolates were 
singleton. 
 Some studies in several Asian countries  have indicated that Clade 1 was the 
most common [61, 68, 69], with the dominant clade varying by country (clades 6 
and 17 in China [69], clade 4 and 12 in Korea [68]. An analizing C. albicans MLST  
in period time from 2003 to 2011 showed that the major ones were clades 1, 3, and 
17 were found in  Taiwan from 2003 -2011 [128]. Thus, C. albicans MLST in the 
current study showed the exsisting of “asian clades” circulation (clades 3, 5, 12 and 
17 and new Korea clade). MLST also suggested a potential nosocomial 
transmissions of   C. albicans in HUMP  Hospital, since the same DTS clones were 
isolated from different wards, which were DTS 2933 in Obstetric and 
Otorhinophagology wards, DTS 2936 in Surgery and Oncology wards, and DTS 
2937 in Intensive Care unit and Pediatric ward.  
By analyzing MLST, loss of heterozygosity (LOH) was observed 
in VPS13 sequences obtained from two sequential clones (DST299/DST459) 
belonging to the clade 12 isolated from two patients from Internal medicine ward, in 
which DST 459 was later isolated clone. Loss of heterozygosity occurred by change 
W to A in loci VPS13 in DTS 299 (strain 19A) to become DTS 459 (strain 91). 
Forche A. et al showed that LOH rates are elevated during in vitro exposure to 
oxidative stress, heat stress, and antifungal drugs in C. albicans [163] and stress-
indu ced LOH could speed evolution of Candida specifically when it is poorly 
adapted to its environment [164]. LOH observed in this study reflected the C. 
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albicans stress adaptation in hospital enviromental. In fact, antifungal susceptibility 
test showing DTS 459 was resistant to caspofungine while DTS 299 was not. 
5.3. H. pylori detection from Candida spp. 
 Candida spp. colonize the gastric organs [91], and they are invasive to 
epithelium cells in some circumstances [100]. Candida spp. could supply a niche 
for H. pylori to survive inside as described by Siavoshi and coworkers. They gave 
evidence that Candida vacuoles can be a niche for H. pylori, and suggeted that 
ergosterol source at fungal membrane supply nutrition for H. pylori [101]. H. pylori 
is normally found in gastric and can be a intracellular microorganism in certain 
conditions [98, 99]. The interaction between fungi and bacteria can lead to the 
increase of antimicrobial resistance [95]. A resistant H. pylori for antibiotic therapy 
has become a major concern all over the world. Therefore, a symbiosis between H. 
pylori and Candida spp. could relate to resistant abilily of this bacteria. Recently, a 
study from Vietnam showed that the frequency of resistant H. pylori to 
clarithromycin, levofloxacin, metronidazole and amoxicillin were 42.4%, 41.3%, 
76.1% and 1.15%  respectively [165]. 
In order to excluding all H. pylori from yeast surface, we subcultured 
Candida isolates strains five time on Sabouraud dextrose agar with antibiotic 
(chloramphenicol and penicillin) before Candida DNA extraction process.  
This study indicated  that nearly 15% of the Candida spp tested was positive 
for the H. pylori ureaA gene at first or second step of nested PCR. H. pylori was 
detected from different Candida spp. including C. albicans, C. tropicalis and C. 
orthopsilosis isolated from gastric drainage fluid, oral, sputum and vaginal 
secrection. Previously other authors detected H. pylori specific  genes from the 
whole DNA of Candida spp. isolated from oral and gastric [166], or from mothers' 
vaginal yeasts, mothers' oral yeasts and neonates' oral yeasts [167]. 
Our result suggest that only Candida species having hyphae (C. albicans, C. 
tropicalis) or pseudohyphae (C.  orthopsilosis) could contain H. pylori because the 
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process related to invasive epithelium cell of both fungi and bacteria. In addition, 
the increasing of using multiple antibiotic or broad spectrum antibiotic in case 
having failure in antibiotic therapy for H. pylori trigger for an increasing of 
Candida in the stomach [168] or changing of the morphology by expression hyphae 
[169]. As a result, H. pylori escaped inside the fungi could be protected by the 
antibiotic action. Moreover, the presence of co-infection of Candida and bacteria in 
human diseases are complicated, and has important role for management, especially 
in  treatment incase antimicrobial resistance [93]. In our study, we could not detect 
again H. pylori after storage of Candida strains at -80
0
C, and our experiments 
showed that it could not culture H. pylori from Candida broken cell by cultivate on 
Columbia blood agar in anaerobic condition. It suggest that H. pylori could not live 
inside Candida spp in hospital enviromental since it has just been identify inside 
one of the nosocomial clones circulating between wards. It is not clear to confirm 
which conditions triggered the invasion of H. pylori into Candida vacuoles and 
release of this bacteria from fungi. Therefore further studies are necessary to better 
understand the symbiosis between H. pylori and Candida spp.  
In conclusion, our results gave an overview of Candida spp. causatives and 
epidemiology in Central Vietnam, it is useful to provide a better management 
strategies, preventive measures, and treatment to Candida spp. infections in 
Vietnam. This study is also primary showing an evidence of H. pylori presence only 
in Candida isolates forming hyphae or pseudohyphae. Additional and extensive 
studies are necessary to clarify the symbiosis between these two microorganism. 
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6. CONCLUSION 
 A diverse number of Candida species were isolated from samples obtained 
from Hue University of Medicine and Pharmacy Hospital and Hue Central Hospital. 
The dominant species was C. albicans (47.96%) and C. tropicalis was the second 
most frequently isolated (16.33%). Different percentage of C. albicans and C. non 
albicans were recovered in candida colonization and candidiasis, with C. non 
albicans found in higher proportions in candida colonization, and C. albicans in 
mucosal candidiasis. 
A significantly high rate of resistance to triazole (Fluconazole, itraconazole 
and voriconazole) was found in C. tropicalis, C. orthopsilosis, C. krusei, C. 
digboiensis, C. guilliermondii and C. mesorugosa. Two mutations in the erg11 gene 
(A395T and C461T) that correspond to Y132F and S154F amino acid  substitutions 
in the ERG11 protein were detected from 26.67% of fluconazole resistant C. 
tropicalis isolates.  
A high percentage of C. albicans carried all 3 virulent genes (als1, hwp1 and 
sap4) regardless of the sample source, which confirmed their capacity to be a 
causative in fungal diseases. C.albicans MLST results suggested the presence of 
“asiatic clades” (clades 3, 5, 12 and 17 and new Korea clade) in Central Vietnam, 
and provided  an evidence for potential nosocomial transmissions of  C. albicans in  
hospital wards.  
After excluding the presence of H. pylori in Candida surface, a H.pylori 
specific ureA gene was found in 15.27% of Candida spp, including C. albicans, C. 
tropicalis, C. orthopsilosis, and from different sample sources, such as oral mucosa, 
sputum, vaginal secretion, gastric fluid. These species could form hyphae and 
pseudohyphae suggesting their possible involvement in H.pylori entrance into yeast, 
and they might supply a good niche that preserve H.pylory from antimicrobial 
therapy. Further studies are necessary to better understand the symbiosis between H. 
pylori and Candida spp. and if also bacteria is able to take advantage of fungal 
resources in mutualistic interactions. 
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